Covid-19 confirmed case

U22_COVID19_CONFIRMED

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — U071 Cause of death: ICD-10 — U071 2 out of 7 registries used, show all original rules.	13142
4. Check minimum number of events None	13142
5. Include endpoints None	13142
6. Filter based on genotype QC (FinnGen only)	13142

Control definitions (FinnGen only)

Control conditions: not U22_COVID19_SUSPECTED

Extra metadata

First used in FinnGen datafreeze: DF6

NAME	U22_COVID19_CONFIRMED
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS	!U22_COVID19_SUSPECTED
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	U071
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	U071
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Covid-19 confirmed case based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	39717	19767	19395
Only index persons	34107	17397	16710
Unadjusted period prevalence (%)
Whole population	0.55	0.57	0.54
Only index persons	0.64	0.64	0.64
Median age at first event (years)
Whole population	38.47	38.63	38.37
Only index persons	42.30	42.00	42.60

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	13142	7283	5859
Unadjusted period prevalence (%)	2.53	2.48	2.58
Median age at first event (years)	62.72	56.34	70.64

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
8838: Matched controls
88378

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

4503599627370496.0

323.0

8836

9151

J12.8

ICD-10 Finland

Other viral pneumonia

551.0

323.0

941

Z20.8

ICD-10 Finland

Contact with and exposure to other communicable diseases

3.8

301.5

1434

4252

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.7

270.3

2351

10580

Z20.9

ICD-10 Finland

Contact with and exposure to unspecified communicable disease

6.0

221.1

653

1164

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

198.4

3710

23301

R06.0

ICD-10 Finland

Dyspnoea

2.1

155.1

2211

12149

R4110

NOMESCO Finland

Physiotherapy

2.0

150.2

2372

13562

R83

ICPC

Respiratory infection other

1.9

142.0

2569

15412

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.8

139.9

4264

30492

R53

ICD-10 Finland

Malaise and fatigue

2.1

136.4

1958

10699

U09.9

ICD-10 Finland

Post COVID-19 condition, unspecified

14.3

134.4

234

168

A28

ICPC

Limited function/disability NOS

2.4

132.7

1253

5629

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.3

127.1

1348

6412

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.0

120.0

776

2784

R50.9

ICD-10 Finland

Fever, unspecified

2.2

115.8

1393

6997

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.5

112.9

959

4049

Z29.8

ICD-10 Finland

Other specified prophylactic measures

5.0

111.3

378

784

Z71.8

ICD-10 Finland

Other specified counselling

1.8

108.4

2242

13843

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

108.4

1792

10220

C03CA01

ATC

furosemide; systemic

1.9

105.8

1960

11634

M79.6

ICD-10 Finland

Pain in limb

1.7

102.1

2937

20024

A02BC02

ATC

pantoprazole; systemic

1.6

99.6

5090

40425

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.4

96.4

501

1533

H02AB06

ATC

prednisolone; systemic

1.6

94.6

3713

27396

Z29.0

ICD-10 Finland

Isolation

23.8

94.2

136

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.1

93.7

1152

5796

XF400

NOMESCO Finland

ECG with 12 standard connections

2.0

93.4

1333

7132

N02BE01

ATC

paracetamol; systemic, rectal

1.7

92.1

7150

62743

AA1AD

NOMESCO Finland

CT of head and brain

1.8

88.7

1787

10821

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

83.2

2007

12831

U08.9

ICD-10 Finland

Personal history of COVID-19, unspecified

14.8

82.6

141

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.9

82.6

1471

8518

R5110

SPAT

4.5

79.5

294

666

WX402

NOMESCO Finland

General anaesthesia

1.8

78.1

1437

8397

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

2.1

76.9

1002

5137

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

75.8

3000

21810

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

74.5

1521

9185

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.7

74.4

549

2122

L28

ICPC

Limited function/disability (L)

1.9

73.1

1166

6463

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

71.4

2998

22020

R02

ICPC

Shortness of breath/dyspnoea

2.0

69.4

993

5271

R03AC02

ATC

salbutamol; inhalant

1.5

69.0

4276

34167

J01DB01

ATC

cefalexin; oral

1.6

67.6

6889

61193

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

66.1

1424

8711

I50.9

ICD-10 Finland

Heart failure, unspecified

2.1

66.0

860

4393

L04AA06

ATC

mycophenolic acid; systemic

4.9

66.0

227

477

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

65.5

2189

15139

JN3AD

NOMESCO Finland

Abdominal CT examination

2.3

63.0

635

2891

A78

ICPC

Infectious disease other/NOS

3.9

62.9

271

709

GD1AD

NOMESCO Finland

Thorax CT examination

3.0

62.5

384

1320

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.2

62.2

674

3174

TK800

NOMESCO Finland

Hemodialysis

4.1

61.1

251

629

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.7

60.6

1525

9742

N02AX02

ATC

tramadol; systemic, rectal

1.5

59.6

3059

23243

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

59.2

1089

6312

SPAT1263

SPAT

Sampling

1.5

59.1

3536

27717

WX110

NOMESCO Finland

Local anesthesy

1.5

58.8

5781

49935

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.8

58.5

1215

7320

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

1.8

57.8

1025

5861

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.8

57.8

1084

6318

R60.0

ICD-10 Finland

Localized oedema

2.0

57.2

808

4251

R51.80

ICD-10 Finland

Headache

1.7

56.9

1278

7886

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

56.3

4201

34268

M54.5

ICD-10 Finland

Low back pain

1.5

56.2

2580

19078

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.6

56.2

2021

14138

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

4.1

56.1

229

571

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.9

55.4

953

5392

N30.0

ICD-10 Finland

Acute cystitis

1.8

54.6

1091

6484

WX892

NOMESCO Finland

Monitored bed care

2.2

54.1

608

2904

N03AX16

ATC

pregabalin; oral

1.6

54.0

1680

11319

R74

ICPC

Upper respiratory infection acute

1.5

53.8

2512

18607

J12.9

ICD-10 Finland

Viral pneumonia, unspecified

8.8

53.6

117

134

C07AB07

ATC

bisoprolol; oral

1.4

52.9

3079

23840

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.9

52.6

229

605

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

52.6

2050

14577

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

52.5

2045

14539

R11

ICD-10 Finland

Nausea and vomiting

2.0

51.5

680

3477

127

Kela drug reimbursment

Transplant complication

4.5

51.1

186

416

A46

ICD-10 Finland

Erysipelas

1.8

50.9

976

5712

R42

ICD-10 Finland

Dizziness and giddiness

1.6

50.9

1507

10009

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

50.8

1455

9581

J01MA12

ATC

levofloxacin; systemic

1.7

50.3

1311

8414

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.5

48.3

414

1731

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.1

48.1

610

3068

WX002

NOMESCO Finland

Sedation and analgesia

1.6

47.7

1394

9210

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

47.2

1793

12622

N18.8

ICD-10 Finland

Other chronic renal failure

3.4

47.0

242

734

R05

ICPC

Cough

1.5

46.8

1716

11982

C08CA01

ATC

amlodipine; oral

1.5

46.5

2195

16189

R03BB04

ATC

tiotropium bromide; inhalant

2.0

46.2

662

3494

XF600

NOMESCO Finland

Bloodpressure measurement

2.1

45.6

524

2524

R05

ICD-10 Finland

Cough

1.6

45.5

1395

9322

B34.2

ICD-10 Finland

Coronavirus infection, unspecified site

8.2

45.2

103

127

U07.2

ICD-10 Finland

COVID-19, virus not identified

1.6

44.9

1477

10039

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.4

44.6

408

1766

Z49.1

ICD-10 Finland

Extracorporeal dialysis

4.6

44.4

160

355

ZX120

NOMESCO Finland

Intravenous

1.9

44.3

721

3983

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

44.1

840

4896

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.0

43.9

614

3209

TPH07

NOMESCO Finland

Cathetrisation of artery

1.9

43.8

741

4147

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

43.2

2576

19837

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

43.0

3598

29419

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

42.9

1205

7860

J01MA02

ATC

ciprofloxacin; systemic

1.4

42.8

2743

21402

A04

ICPC

Weakness/tiredness general

1.7

42.6

1041

6536

S18

ICPC

Laceration/cut

1.4

42.6

2978

23587

Z25.1

ICD-10 Finland

Need for immunization against influenza

2.2

42.5

447

2069

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

5.6

42.5

128

233

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

42.4

1739

12409

B03XA02

ATC

darbepoetin alfa; parenteral

4.0

41.6

173

440

Z20.2

ICD-10 Finland

Contact with and exposure to infections with a predominantly sexual mode of transmission

2.7

41.6

294

1105

B01AF02

ATC

apixaban; oral

1.9

41.5

613

3266

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.6

41.3

307

1187

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.4

41.1

362

1537

Z94.0

ICD-10 Finland

Kidney transplant status

4.8

40.9

140

295

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.8

40.8

762

4410

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.9

40.6

658

3629

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

40.6

3403

27743

WVA20

NOMESCO Finland

Medicine administration

3.2

40.5

218

684

JN4AD

NOMESCO Finland

Body CT examination

2.0

40.1

522

2647

A02BC05

ATC

esomeprazole; systemic

1.4

40.1

2817

22273

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.9

40.1

612

3303

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

39.8

767

4480

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.0

39.8

112

188

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.7

39.7

850

5131

U08

ICD-10 Finland

Personal history of COVID-19

10.6

39.3

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

3.1

39.0

218

704

A03

ICPC

Fever

1.5

38.9

1383

9538

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.3

38.6

376

1677

WX723

NOMESCO Finland

CPAP therapy

2.6

38.5

294

1154

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

38.3

654

3667

SPAT1260

SPAT

Consultation of another employee

1.5

37.5

1334

9190

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

4.8

37.5

127

265

A98

ICPC

Health maint/preventive medicine

1.8

37.1

8373

80360

ZXA05

NOMESCO Finland

Left side

1.5

37.0

1664

12067

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

36.8

1127

7488

R52.9

ICD-10 Finland

Pain, unspecified

1.9

36.8

615

3423

A11CC03

ATC

alfacalcidol; systemic

3.2

36.7

197

618

SPAT1301

SPAT

No procedures

1.4

36.7

2393

18611

R5140

NOMESCO Finland

Monitoring the use of the aid

1.8

36.6

716

4201

U09

ICD-10 Finland

Post COVID-19 condition

5.3

36.4

113

214

A06AD11

ATC

lactulose; oral

1.7

36.1

893

5609

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

35.8

1982

14950

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

35.6

3170

25924

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

35.5

1734

12767

R4190

NOMESCO Finland

Nutritional therapy

2.4

35.2

303

1273

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.7

34.9

756

4571

B01AB05

ATC

enoxaparin; parenteral

1.4

34.7

1986

15058

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

5.2

34.7

110

214

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

7.6

34.5

109

Z01.7

ICD-10 Finland

Laboratory examination

1.7

34.2

804

4975

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.8

34.2

575

3207

J01AA02

ATC

doxycycline; systemic

1.3

34.2

5818

52256

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.7

33.9

239

896

SPAT1312

SPAT

General health counselling

1.4

33.8

2578

20525

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.6

33.6

260

1028

L17

ICPC

Foot/toe symptom/complaint

1.4

33.5

1767

13182

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.7

33.1

739

4505

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.9

32.9

541

2993

ZXA10

NOMESCO Finland

Bilateral

1.5

32.8

1266

8860

P01AB01

ATC

metronidazole; oral, rectal

1.3

32.8

2822

22878

J45

ICD-10 Finland

Asthma

1.7

32.8

716

4339

SPAT1254

SPAT

Administration of medicine

1.5

32.7

1116

7600

R01AD12

ATC

fluticasone furoate; nasal

1.4

32.7

2295

18002

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.7

32.7

725

4413

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

32.6

1159

7963

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.8

32.6

645

3795

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.5

32.5

263

1068

XW000

NOMESCO Finland

Bone marrow biopsy

2.4

32.4

288

1230

N05CF01

ATC

zopiclone; oral

1.4

32.2

2076

16043

UJF32

NOMESCO Finland

Coloscopy

1.4

32.1

1638

12134

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

32.1

991

6587

Z49.2

ICD-10 Finland

Other dialysis

6.3

31.8

138

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

4.0

31.8

130

328

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

2.1

31.8

371

1800

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.8

31.7

618

3616

XF404

NOMESCO Finland

Ambulatory ECG

1.8

31.7

616

3604

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

31.7

1534

11245

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.0

31.6

410

2077

K59.09

ICD-10 Finland

Constipation, unspecified

2.0

31.6

412

2091

J01CA04

ATC

amoxicillin; systemic

1.4

31.5

6751

62302

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.6

31.4

936

6165

137

Kela drug reimbursment

Uraemia requiring dialysis

5.2

31.4

192

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

31.2

1347

9647

R33

ICD-10 Finland

Retention of urine

1.9

31.2

490

2667

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.8

31.1

586

3389

J20

ICD-10 Finland

Acute bronchitis

1.7

31.1

672

4060

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.0

31.0

399

2017

Z01.9

ICD-10 Finland

Special examination, unspecified

2.0

30.9

390

1955

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

30.4

1677

12583

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.5

30.4

1095

7536

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.5

30.4

1009

6816

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

30.4

5696

51359

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

30.3

627

3735

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.4

30.2

1530

11299

J01MA14

ATC

moxifloxacin; systemic

1.7

30.1

601

3542

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.7

29.8

604

3576

J01FF01

ATC

clindamycin; systemic

1.4

29.5

1902

14662

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.9

29.4

186

653

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

29.4

716

4472

M25.5

ICD-10 Finland

Pain in joint

1.4

29.3

2014

15689

ZXA00

NOMESCO Finland

Right side

1.4

29.3

1732

13152

K02.1

ICD-10 Finland

Caries of dentine

1.3

29.2

4573

40128

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.3

28.9

4193

36398

R07.3

ICD-10 Finland

Other chest pain

1.7

28.9

616

3704

G47.3

ICD-10 Finland

Sleep apnoea

1.4

28.8

1385

10115

S97

ICPC

Chronic ulcer skin

2.0

28.7

358

1785

M04AA01

ATC

allopurinol; systemic

1.6

28.7

739

4685

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

28.6

1691

12833

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

28.4

636

3875

V03AE01

ATC

polystyrene sulfonate; oral

4.2

28.4

110

265

R55

ICD-10 Finland

Syncope and collapse

1.6

28.3

697

4363

TGC00

NOMESCO Finland

Bronchial lavation

2.7

28.2

194

719

A12AA04

ATC

calcium carbonate; oral

3.4

28.2

139

411

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.1

28.1

340

1676

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.3

27.9

2213

17609

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.1

27.9

320

1543

J46

ICD-10 Finland

Status asthmaticus

2.5

27.8

221

890

N05BA04

ATC

oxazepam; oral

1.4

27.8

1705

13011

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.1

27.8

154

497

J45.1

ICD-10 Finland

Nonallergic asthma

1.8

27.4

496

2832

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.6

26.9

202

789

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.0

26.8

339

1701

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.8

26.6

474

2696

WX780

NOMESCO Finland

Remote monitoring CPAP

2.2

26.6

284

1328

H02AB04

ATC

methylprednisolone; systemic

1.5

26.4

937

6416

R03DC03

ATC

montelukast; oral

1.5

26.4

1122

7984

SPAT1262

SPAT

Handing over of treatment supplies

1.4

26.2

1185

8539

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.8

26.2

483

2774

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.3

26.2

133

403

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.9

26.2

404

2186

S06.0

ICD-10 Finland

Concussion

1.6

26.1

755

4928

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.8

25.9

459

2602

R4120

NOMESCO Finland

Occupational therapy

1.8

25.9

438

2444

TKC20

NOMESCO Finland

Catheterisation of bladder

1.8

25.9

457

2590

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

25.9

1052

7416

L04AX01

ATC

azathioprine; systemic

2.0

25.8

333

1683

N19

ICD-10 Finland

Unspecified kidney failure

2.5

25.8

206

835

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.8

25.7

475

2730

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.3

25.6

133

410

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

5.8

25.5

127

N05AH04

ATC

quetiapine; oral

1.4

25.4

1221

8897

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

25.2

1222

8917

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

25.2

1323

9803

B05DA

ATC

Isotonic solutions

5.3

25.2

149

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

25.0

1088

7773

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.2

25.0

134

423

SPAT1229

SPAT

Assessment of need for aid

1.7

24.9

491

2881

207

Kela drug reimbursment

Chronic arrhythmias

1.6

24.8

779

5184

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.4

24.8

223

961

N05AH02

ATC

clozapine; systemic

2.7

24.7

177

674

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

3.2

24.7

130

405

SPAT1310

SPAT

Counselling related to known health issue

1.3

24.6

2400

19615

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.9

24.6

393

2150

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

4.5

24.5

193

Z49.0

ICD-10 Finland

Preparatory care for dialysis

4.2

24.5

230

WZC30

NOMESCO Finland

Teaching

1.5

24.4

859

5867

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.7

24.4

523

3146

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

24.4

3054

25805

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.1

24.4

273

1302

N03AX12

ATC

gabapentin; oral

1.5

24.4

985

6933

I50.0

ICD-10 Finland

Congestive heart failure

1.9

24.2

384

2095

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

24.2

1456

11042

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

4.9

24.0

166

TK820

NOMESCO Finland

Peritoneal dialysis

7.1

24.0

P20

ICPC

Memory disturbance

1.6

23.9

634

4046

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.9

23.8

381

2087

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

23.8

1514

11585

R81

ICPC

Pneumonia

2.3

23.8

228

1013

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.0

23.8

298

1490

SAD02

NOMESCO Finland

Assessment of need for oral health care, extensive

1.9

23.8

376

2051

V03AE03

ATC

lanthanum carbonate; oral

8.2

23.8

E0000UV

ATC

1.3

23.4

2907

24504

I48.2

ICD-10 Finland

Chronic atrial fibrillation

2.7

23.4

162

606

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.8

23.4

392

2181

R4110

SPAT

2.4

23.4

202

853

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.5

23.4

183

734

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.7

23.2

511

3100

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.4

23.1

1310

9827

M79.1

ICD-10 Finland

Myalgia

1.5

23.0

897

6262

E66.01

ICD-10 Finland

Obesity due to excess calories

1.6

22.8

576

3626

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.5

22.7

180

727

R21

ICPC

Throat symptom/complaint

1.3

22.7

1665

13031

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.0

22.6

300

1536

E86

ICD-10 Finland

Volume depletion

2.7

22.5

161

614

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

22.5

834

5757

N17.8

ICD-10 Finland

Other acute renal failure

3.8

22.5

254

S01.0

ICD-10 Finland

Open wound of scalp

1.7

22.4

473

2835

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

3.6

22.3

102

286

WX726

NOMESCO Finland

High-flow oxygen therapy

16.7

22.2

N05BA01

ATC

diazepam; systemic, rectal

1.5

22.2

847

5885

UKC02

NOMESCO Finland

Cystoscopy

1.5

22.0

941

6693

Z00.8

ICD-10 Finland

Other general examinations

1.7

22.0

517

3191

M10.9

ICD-10 Finland

Gout, unspecified

1.8

21.8

373

2089

N30.9

ICD-10 Finland

Cystitis, unspecified

1.8

21.8

373

2090

V03AE02

ATC

sevelamer; oral

5.7

21.8

112

N17

ICPC

Vertigo/dizziness

1.5

21.7

697

4657

R60.9

ICD-10 Finland

Oedema, unspecified

2.0

21.7

295

1524

K07

ICPC

Swollen ankles/oedema

2.1

21.6

255

1244

G44.2

ICD-10 Finland

Tension-type headache

1.5

21.6

925

6576

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

21.6

1182

8803

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

2.1

21.6

259

1274

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.8

21.6

350

1928

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

8.2

21.6

D11

ICPC

Diarrhoea

1.5

21.4

846

5918

G04BD12

ATC

mirabegron; oral

1.6

21.4

567

3618

N18.0

ICD-10 Finland

End-stage renal disease

3.5

21.3

101

292

N01

ICPC

Headache

1.5

21.2

862

6061

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

21.2

868

6117

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.0

21.1

269

1355

WX320

NOMESCO Finland

Spinalanesthesy

1.4

20.9

1423

10991

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.6

20.8

621

4081

WW200

NOMESCO Finland

Immunization

2.2

20.8

220

1025

XG466

NOMESCO Finland

Sleep oxymetry

2.2

20.7

220

1027

A02BC01

ATC

omeprazole; systemic

1.3

20.7

1769

14129

C09AA05

ATC

ramipril; oral

1.4

20.7

1384

10656

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

20.7

1177

8822

N06AX11

ATC

mirtazapine; oral

1.3

20.6

2148

17637

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.8

20.6

375

2147

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.5

20.6

752

5174

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.1

20.5

246

1209

M10.0

ICD-10 Finland

Idiopathic gout

2.3

20.4

195

868

L03

ICPC

Low back symptom/complaint

1.3

20.4

1661

13176

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.6

20.4

528

3348

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.4

20.3

1081

8005

WX290

NOMESCO Finland

Other blockade of nerve

1.2

20.3

3520

30726

R07.0

ICD-10 Finland

Pain in throat

1.7

20.3

462

2828

WZA10

NOMESCO Finland

Long statement of health and health related matters

3.0

20.2

117

392

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

20.2

1198

9040

Z48.0

ICD-10 Finland

Attention to surgical dressings and sutures

2.1

20.2

242

1192

I50

ICD-10 Finland

Heart failure

2.4

20.1

178

762

A11

ICPC

Chest pain NOS

1.7

20.1

452

2756

Z73.6

ICD-10 Finland

Limitation of activities due to disability

4.0

20.1

200

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.6

20.1

611

4031

N05AX08

ATC

risperidone; systemic

1.6

20.0

499

3130

M01AH05

ATC

etoricoxib; oral

1.2

20.0

4115

36583

K08.3

ICD-10 Finland

Retained dental root

1.7

19.9

437

2646

H02AB07

ATC

prednisone; oral

1.4

19.9

875

6249

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.5

19.8

697

4753

X58

ICD-10 Finland

Exposure to other specified factors

1.4

19.7

958

6975

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.7

19.7

430

2599

N06AX16

ATC

venlafaxine; oral

1.4

19.7

951

6914

B05DB

ATC

Hypertonic solutions

5.1

19.7

122

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.0

19.7

243

1210

R4130

NOMESCO Finland

Speech therapy

2.5

19.6

159

651

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.3

19.6

188

838

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

3.7

19.5

240

R06AE07

ATC

cetirizine; oral

1.2

19.4

3222

27939

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.6

19.4

500

3168

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.4

19.3

169

719

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.0

19.3

235

1165

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.5

19.2

691

4733

L04AD01

ATC

ciclosporin; systemic

2.6

19.2

146

577

R03BA02

ATC

budesonide; inhalant

1.4

19.1

1162

8795

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.5

19.1

737

5128

-1

NOMESCO Finland

1.3

19.1

2613

22157

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.7

19.0

446

2754

A01

ICPC

Pain general/multiple sites

1.6

18.8

488

3091

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

4.2

18.8

169

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.8

18.8

336

1913

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.0

18.8

241

1220

B01AC04

ATC

clopidogrel; oral

1.4

18.8

829

5924

M54

ICD-10 Finland

Dorsalgia

1.5

18.8

782

5527

J01FA06

ATC

roxithromycin; oral

1.2

18.8

2730

23301

C10AA05

ATC

atorvastatin; oral

1.3

18.8

2093

17298

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.6

18.6

519

3352

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.4

18.6

1163

8842

U02

ICPC

Urinary frequency/urgency

1.4

18.6

829

5935

H25.1

ICD-10 Finland

Senile nuclear cataract

1.4

18.5

1210

9264

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.5

18.5

586

3901

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.6

18.5

446

2773

XCK10

NOMESCO Finland

Photography of fundus of eye

1.5

18.5

593

3962

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

3.8

18.5

211

S29

ICPC

Skin symptom/complaint other

1.4

18.4

1082

8142

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

18.4

1137

8626

D10

ICPC

Vomiting

1.6

18.3

478

3033

N03AG01

ATC

valproic acid; systemic, rectal

1.7

18.2

414

2534

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

1.9

18.2

259

1361

WX302

NOMESCO Finland

Thoracal epidural anesthesy

1.8

18.2

321

1818

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

5.1

18.2

112

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.1

18.2

220

1086

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.8

18.2

118

427

XX3DW

NOMESCO Finland

Time consuming IT work

1.5

18.2

594

3982

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

18.1

1864

15236

SPAT1255

SPAT

Intravenous administration of medicine

1.7

18.1

416

2555

E66.8

ICD-10 Finland

Other obesity

1.7

18.1

356

2090

D01

ICPC

Abdominal pain/cramps general

1.4

18.0

770

5468

R03BA01

ATC

beclometasone; inhalant

1.4

17.9

867

6305

196

Kela drug reimbursment

Paricalcitol and cinacalcet

5.2

17.9

106

MA2XE

NOMESCO Finland

Other obstetric ultrasound examination

1.6

17.9

456

2881

R4180

NOMESCO Finland

Podiatric therapy

3.5

17.8

238

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.5

17.8

557

3696

F20.9

ICD-10 Finland

Schizophrenia, unspecified

2.3

17.8

159

686

MA2DE

NOMESCO Finland

Detailed ultrasound examination of fetus including color doppler method

1.5

17.7

601

4065

NF1AA

NOMESCO Finland

Hip X-ray examination

1.6

17.7

456

2884

R10.0

ICD-10 Finland

Acute abdomen

2.0

17.7

226

1143

SPAT1216

SPAT

Assessment of functional ability

1.4

17.7

900

6603

XKD00

NOMESCO Finland

Uroflowmetry

1.4

17.6

890

6519

J05AB01

ATC

aciclovir; systemic

1.3

17.6

1374

10805

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.7

17.6

376

2261

ZX108

NOMESCO Finland

Inhalation

4.0

17.5

172

R39.1

ICD-10 Finland

Other difficulties with micturition

2.1

17.4

189

896

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.4

17.3

921

6810

Z34.9

ICD-10 Finland

Supervision of normal pregnancy, unspecified

1.4

17.3

764

5460

J01EA01

ATC

trimethoprim; systemic

1.3

17.3

1626

13121

A10AE04

ATC

insulin glargine; parenteral

1.5

17.3

582

3931

R52.0

ICD-10 Finland

Acute pain

2.0

17.3

224

1138

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.5

17.2

622

4266

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.7

17.2

382

2325

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

17.2

910

6725

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.2

17.1

4038

36175

SPAT1053

SPAT

Memory test

1.4

17.1

738

5245

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

17.1

638

4404

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

3.8

17.0

191

W19

ICD-10 Finland

Unspecified fall

1.5

17.0

592

4025

A41.9

ICD-10 Finland

Sepsis, unspecified

2.0

17.0

222

1132

R03BA05

ATC

fluticasone; inhalant

1.3

16.9

1229

9559

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

2.5

16.9

136

557

J01FA10

ATC

azithromycin; systemic

1.2

16.9

4468

40467

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

16.8

3596

31874

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

2.0

16.8

206

1026

G04CA02

ATC

tamsulosin; oral

1.3

16.8

1216

9450

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.7

16.8

325

1899

B01AB10

ATC

tinzaparin; parenteral

1.6

16.7

410

2561

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

5.5

16.7

N02AA05

ATC

oxycodone; systemic

1.4

16.7

789

5710

R31

ICD-10 Finland

Unspecified haematuria

1.5

16.6

558

3763

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.6

16.6

462

2983

T90

ICPC

Diabetes non-insulin dependent

1.3

16.5

1281

10059

R96

ICPC

Asthma

1.5

16.5

531

3551

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.7

16.4

347

2081

R03AK11

ATC

formoterol and fluticasone; inhalant

2.2

16.4

161

727

C01DA14

ATC

isosorbide mononitrate; oral

1.4

16.4

758

5464

WX213

NOMESCO Finland

Lower leg blockade

3.8

16.4

178

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

16.4

886

6571

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.7

16.3

336

2001

E87.5

ICD-10 Finland

Hyperkalaemia

2.9

16.3

101

356

I48.1

ICD-10 Finland

Persistent atrial fibrillation

2.3

16.3

150

659

J01FA09

ATC

clarithromycin; systemic

1.2

16.3

2183

18392

WX872

NOMESCO Finland

Intensive care

1.8

16.3

302

1743

WX730

NOMESCO Finland

Conventional respirator

2.6

16.2

115

440

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.5

16.2

594

4087

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.8

16.2

262

1445

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.6

16.2

396

2473

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

16.1

1557

12598

SCA02

NOMESCO Finland

Analysis and advice of nutrition with regard to dentistry

1.4

16.1

790

5755

SPAT1172

SPAT

Guidance concerning hydration

2.4

16.1

134

559

I95.1

ICD-10 Finland

Orthostatic hypotension

2.1

16.1

186

902

H92.0

ICD-10 Finland

Otalgia

1.7

16.1

349

2110

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

2.9

16.1

340

Z02.7

ICD-10 Finland

Issue of medical certificate

1.6

16.0

406

2558

WX110

SPAT

1.7

16.0

307

1790

M48.0

ICD-10 Finland

Spinal stenosis

1.5

15.9

621

4328

N06AB04

ATC

citalopram; systemic

1.3

15.9

1359

10816

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.3

15.9

1326

10519

K03.66

ICD-10 Finland

Tooth plaque

1.6

15.8

427

2737

103

Kela drug reimbursment

Diabetes, insulin-treated

1.3

15.8

1531

12393

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

4.4

15.8

127

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.1

15.7

174

830

WW500

NOMESCO Finland

Blood transfusion

1.8

15.7

253

1395

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

15.7

374

2320

SPAT1234

SPAT

Support of social functional capacity

1.7

15.7

302

1761

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.1

15.7

181

880

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

15.6

2443

20918

E87.6

ICD-10 Finland

Hypokalaemia

2.1

15.6

181

883

A04AA01

ATC

ondansetron; systemic, rectal

1.6

15.6

387

2427

GD1AA

SPAT

1.5

15.5

478

3161

Z39.2

ICD-10 Finland

Routine postpartum follow-up

1.4

15.5

946

7152

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.4

15.5

132

557

H81

ICPC

Excessive ear wax

1.4

15.5

904

6790

F05.9

ICD-10 Finland

Delirium, unspecified

2.5

15.4

122

494

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.4

15.4

639

4510

SPAT1167

SPAT

Insertion of urinary catheter

2.1

15.4

181

888

N05AH03

ATC

olanzapine; systemic

1.6

15.3

407

2599

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

15.3

885

6634

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.6

15.3

355

2188

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

15.3

835

6199

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.9

15.3

221

1172

R03AK08

ATC

formoterol and beclometasone; inhalant

1.9

15.2

237

1293

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1.8

15.2

255

1424

XG410

NOMESCO Finland

Flow-volume spirometry

1.8

15.1

257

1442

Z94.2

ICD-10 Finland

Lung transplant status

9.1

15.1

LCA06

NOMESCO Finland

Biopsy of endometrium

1.4

15.1

653

4643

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.8

15.1

282

1629

M01AB05

ATC

diclofenac; systemic, rectal

1.2

15.0

4753

43567

SCA03

NOMESCO Finland

Preventive oral health care, extensive

1.6

15.0

350

2161

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.4

15.0

744

5429

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.8

15.0

272

1561

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.4

14.9

671

4812

TK810

NOMESCO Finland

Hemofiltration

4.0

14.9

144

N05AA02

ATC

levomepromazine; systemic

1.8

14.9

253

1421

SPAT1324

SPAT

Screening procedure

0.7

14.9

672

9000

GD2SN

NOMESCO Finland

Lung ventilation SPECT

4.2

14.8

135

E66.00

ICD-10 Finland

Metabolic syndrome

1.7

14.8

325

1971

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.5

14.8

554

3828

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.2

14.8

150

688

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.5

14.8

520

3546

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

14.8

698

5048

A48

ICPC

General and Unspecified, Clarification/discussion RFE/demand

1.6

14.8

404

2599

J01DA01

ATC

[U] cefalexin; systemic

1.2

14.8

4600

42066

K04.1

ICD-10 Finland

Necrosis of pulp

1.4

14.8

684

4927

R06.2

ICD-10 Finland

Wheezing

1.7

14.7

275

1593

R00.2

ICD-10 Finland

Palpitations

1.5

14.7

446

2945

WZA00

NOMESCO Finland

Short statement of of health and health related matters

1.6

14.7

415

2691

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.4

14.7

699

5067

S22.3

ICD-10 Finland

Fracture of rib

1.6

14.6

371

2342

R04.2

ICD-10 Finland

Haemoptysis

2.0

14.6

195

1004

-1

ICD-10 Finland

1.8

14.6

267

1533

K04.0

ICD-10 Finland

Pulpitis

1.4

14.6

697

5048

UDC00

NOMESCO Finland

Ear microscopy

1.5

14.6

460

3062

R13

ICD-10 Finland

Dysphagia

1.6

14.6

365

2296

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.5

14.5

492

3326

B02.9

ICD-10 Finland

Zoster without complication

1.7

14.5

306

1838

U05

ICPC

Urination problems other

1.8

14.5

260

1486

3025

Kela drug reimbursment

Calcium carbonate

6.7

14.4

R41.0

ICD-10 Finland

Disorientation, unspecified

2.1

14.4

169

826

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.4

14.4

645

4618

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

2.9

14.4

314

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.1

14.4

159

758

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.4

14.4

600

4240

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

4.3

14.3

121

Z01.2

ICD-10 Finland

Dental examination

1.2

14.3

3029

26697

M03BX02

ATC

tizanidine; oral

1.2

14.3

4434

40486

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.5

14.2

109

437

A10BH05

ATC

linagliptin; oral

1.8

14.2

245

1383

N06AX21

ATC

duloxetine; oral

1.4

14.2

664

4794

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.6

14.1

417

2734

R03BA08

ATC

ciclesonide; inhalant

1.5

14.1

503

3438

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

1.7

14.1

292

1743

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.2

14.1

2005

16961

JN4BD

NOMESCO Finland

Extensive body CT

1.4

14.1

603

4281

N06AB10

ATC

escitalopram; oral

1.3

14.1

1413

11470

R51

ICD-10 Finland

Headache

1.6

14.0

358

2262

N76.0

ICD-10 Finland

Acute vaginitis

1.5

14.0

423

2787

A02BA02

ATC

ranitidine; systemic

1.3

14.0

1101

8648

A10BA02

ATC

metformin; oral

1.3

14.0

1555

12783

WX212

NOMESCO Finland

Femoral plexus blockade

2.5

13.9

111

455

R35

ICD-10 Finland

Polyuria

1.6

13.9

357

2259

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

2.0

13.9

183

938

WW200

SPAT

0.7

13.9

340

5062

C03DA01

ATC

spironolactone; oral

1.5

13.9

567

3986

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

13.8

771

5739

N05AF03

ATC

chlorprothixene; systemic

2.0

13.8

182

933

N03AX09

ATC

lamotrigine; oral

1.6

13.8

331

2057

H02AB09

ATC

hydrocortisone; systemic

2.1

13.8

162

794

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

13.8

182

937

P01BA02

ATC

hydroxychloroquine; oral

1.5

13.6

469

3187

Z00.0

ICD-10 Finland

General medical examination

1.3

13.6

1242

9960

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.7

13.5

299

1821

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.4

13.5

593

4227

A03FA01

ATC

metoclopramide; systemic, rectal

1.3

13.5

1245

9989

J02AC01

ATC

fluconazole; systemic

1.2

13.5

2714

23763

G43.9

ICD-10 Finland

Migraine, unspecified

1.5

13.5

408

2691

S21

ICPC

Skin texture symptom/complaint

1.4

13.5

768

5740

D07AD01

ATC

clobetasol; topical

1.3

13.5

907

6962

M01AE01

ATC

ibuprofen; systemic, rectal

1.2

13.4

7270

69705

WX721

NOMESCO Finland

Oxygen concentrator therapy

9.3

13.4

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.7

13.4

254

1476

NH3EA

NOMESCO Finland

Feet X-ray examination with load

2.2

13.3

137

634

A41.8

ICD-10 Finland

Other specified sepsis

2.4

13.3

107

441

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.2

13.3

2156

18470

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

2.5

13.2

393

SPAT1211

SPAT

Application of soft bandage

1.4

13.1

590

4231

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.3

13.1

123

549

S76

ICPC

Skin infection other

1.7

13.1

294

1798

N05BA06

ATC

lorazepam; systemic, sublingual

1.7

13.0

277

1669

J01CF05

ATC

flucloxacillin; systemic

1.8

13.0

236

1354

XKD06

NOMESCO Finland

Physiologic investigation of micturition

1.9

13.0

174

902

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.7

13.0

285

1734

G40.9

ICD-10 Finland

Epilepsy, unspecified

1.8

13.0

210

1164

A08

ICPC

Swelling

1.8

12.9

236

1359

K08.80

ICD-10 Finland

Toothache NOS

1.5

12.9

511

3569

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.5

12.9

482

3329

321

Kela drug reimbursment

Paricalcitol and cinacalcet

4.4

12.9

106

M54.6

ICD-10 Finland

Pain in thoracic spine

1.5

12.9

407

2710

M81.9

ICD-10 Finland

Osteoporosis, unspecified

1.9

12.9

187

995

L60.0

ICD-10 Finland

Ingrowing nail

1.7

12.8

275

1662

S80.0

ICD-10 Finland

Contusion of knee

1.5

12.8

415

2781

A29

ICPC

General symptom/complaint other

1.4

12.8

649

4755

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

3.1

12.7

225

L03AA02

ATC

filgrastim; parenteral

2.0

12.7

152

754

K59.0

ICD-10 Finland

Constipation

1.6

12.7

308

1925

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.6

12.6

337

2158

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

12.6

5461

51045

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.1

12.6

144

698

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

12.6

1045

8263

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

3.2

12.6

210

N03AE01

ATC

clonazepam; systemic

1.6

12.6

332

2119

M54.3

ICD-10 Finland

Sciatica

1.6

12.6

319

2016

B01AA03

ATC

warfarin; systemic

1.3

12.6

1022

8061

E66

ICD-10 Finland

Obesity

1.7

12.6

264

1586

U04

ICPC

Incontinence urine

1.7

12.6

241

1408

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.2

12.6

1708

14350

M54.2

ICD-10 Finland

Cervicalgia

1.5

12.5

428

2900

L14

ICPC

Leg/thigh symptom/complaint

1.5

12.5

435

2961

U07

ICPC

Urine symptom/complaint other

1.6

12.5

324

2059

H04.10

ICD-10 Finland

Dry eye syndrome

1.4

12.5

551

3934

K30

ICD-10 Finland

Functional dyspepsia

1.4

12.4

616

4493

SPAT1238

SPAT

Brief therapy

2.0

12.4

148

734

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.3

12.4

107

459

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

2.4

12.4

104

440

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

4.0

12.4

120

I20.09

ICD-10 Finland

Unstable angina

1.7

12.4

279

1710

N05CD07

ATC

temazepam; oral

1.4

12.4

603

4384

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

2.3

12.4

109

471

B18.2

ICD-10 Finland

Chronic viral hepatitis C

2.5

12.4

370

H61.2

ICD-10 Finland

Impacted cerumen

1.6

12.4

318

2019

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

1.9

12.3

168

876

M10

ICD-10 Finland

Gout

1.7

12.3

233

1357

L04AB04

ATC

adalimumab; parenteral

2.1

12.3

133

634

M05BX04

ATC

denosumab; parenteral

1.7

12.3

235

1374

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.7

12.3

249

1482

K92.1

ICD-10 Finland

Melaena

1.7

12.2

274

1673

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

2.1

12.2

136

653

XG405

NOMESCO Finland

Education on PEF monitoring

2.4

12.2

100

419

C90.0

ICD-10 Finland

Multiple myeloma

3.1

12.1

211

3AC01

NOMESCO Finland

2.7

12.1

309

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.2

12.1

1757

14860

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

1.7

12.1

233

1363

S20.2

ICD-10 Finland

Contusion of thorax

1.6

12.1

286

1776

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.4

12.0

496

3498

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

1.9

12.0

168

886

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.0

12.0

151

765

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.4

12.0

529

3780

U01

ICPC

Dysuria/painful urination

1.5

11.9

460

3198

A10AE05

ATC

insulin detemir; parenteral

1.6

11.9

338

2196

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

11.9

5085

47356

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

1.9

11.9

183

998

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.7

11.8

231

1360

R09.1

ICD-10 Finland

Pleurisy

2.3

11.8

103

444

A97

ICPC

No disease

1.3

11.8

992

7859

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.6

11.8

268

1648

X57

ICD-10 Finland

Unspecified privation

2.0

11.8

143

716

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.4

11.7

494

3497

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.9

11.7

176

953

B34.9

ICD-10 Finland

Viral infection, unspecified

1.8

11.7

199

1123

MAX99

NOMESCO Finland

Assistance to normal delivery

0.7

11.7

322

4687

NG4AA

NOMESCO Finland

Lower leg X-ray examination

1.9

11.7

175

943

N04AA02

ATC

biperiden; systemic

2.1

11.7

121

567

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

11.6

520

3723

D07AC01

ATC

betamethasone; topical

1.2

11.6

2176

18870

H05BX01

ATC

cinacalcet; oral

4.0

11.6

113

R95

ICPC

Chron obstructive pulmonary disease

2.1

11.6

132

643

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

3.8

11.6

123

J45.8

ICD-10 Finland

Mixed asthma

1.8

11.6

184

1014

EB1AA

SPAT

1.6

11.6

282

1766

ZX140

NOMESCO Finland

Intra articular

3.2

11.6

180

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

1.8

11.5

195

1095

C10AA01

ATC

simvastatin; oral

1.2

11.5

2297

20036

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

4.1

11.5

109

KMAK

NOMESCO Finland

1.2

11.5

3885

35456

J20.5

ICD-10 Finland

Acute bronchitis due to respiratory syncytial virus

4.9

11.5

M54.8

ICD-10 Finland

Other dorsalgia

1.7

11.5

248

1500

J01CA08

ATC

pivmecillinam; oral

1.2

11.5

2615

23088

R07

ICPC

Sneezing/nasal congestion

1.5

11.5

455

3184

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.3

11.4

420

IGV01

NOMESCO Finland

Psychiatric network contact

2.9

11.4

231

X23

ICPC

Fear sexually transm dis female

1.5

11.4

397

2702

WX740

NOMESCO Finland

Nitrogen oxide therapy

4.0

11.4

110

J43.9

ICD-10 Finland

Emphysema, unspecified

2.7

11.4

283

IHA10

SPAT

3.9

11.4

115

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.0

11.4

148

758

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.5

11.4

380

2565

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

1.7

11.4

233

1390

H01

ICPC

Ear pain/earache

1.3

11.3

728

5546

KH1AD

NOMESCO Finland

CT of urinary organs

1.8

11.3

195

1103

S42.2

ICD-10 Finland

Fracture of upper end of humerus

1.7

11.2

232

1388

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.3

11.2

733

5597

D12

ICPC

Constipation

1.8

11.2

187

1047

M05BA04

ATC

alendronic acid; oral

1.5

11.2

368

2473

M54.1

ICD-10 Finland

Radiculopathy

1.7

11.2

216

1266

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.0

11.2

141

716

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.4

11.2

656

4924

FM1QE

NOMESCO Finland

Extensive ultrasound of fetal heart

2.8

11.2

258

WX722

NOMESCO Finland

PEEP

1.6

11.2

260

1609

L12

ICPC

Hand/finger symptom/complaint

1.3

11.2

894

7032

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.6

11.1

297

1905

SPAT1283

SPAT

Restricted health certificate

1.2

11.1

1449

12102

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

1.9

11.1

165

890

B97.2

ICD-10 Finland

Coronavirus as the cause of diseases classified to other chapters

20.0

11.1

L04AA01

ATC

[U] ciclosporin; systemic

2.4

11.0

382

SDA02

NOMESCO Finland

Parodonthologic therapy

1.2

11.0

2244

19599

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.5

11.0

409

2826

N30

ICD-10 Finland

Cystitis

1.4

11.0

470

3341

R01AD09

ATC

mometasone; nasal

1.2

10.9

3153

28369

SPAT1125

SPAT

Stoma care and guidance

2.5

10.9

347

SPAT1232

SPAT

Communication with help of interpreter or assistant

4.0

10.9

105

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.3

10.9

699

5322

R01AD08

ATC

fluticasone; nasal

1.2

10.9

1895

16303

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.4

10.9

492

3529

A10BH01

ATC

sitagliptin; oral

1.4

10.9

481

3437

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

2.4

10.9

367

K77

ICPC

Heart failure

2.2

10.9

107

489

EBA00

NOMESCO Finland

Extraction of tooth

1.2

10.9

2330

20437

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

2.0

10.8

133

668

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.2

10.8

4242

39101

WX882

NOMESCO Finland

High dependency care

1.9

10.8

164

891

L08

ICPC

Shoulder symptom/complaint

1.3

10.8

1076

8710

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.5

10.8

383

2621

O20.9

ICD-10 Finland

Haemorrhage in early pregnancy, unspecified

1.8

10.8

192

1100

J96.0

ICD-10 Finland

Acute respiratory failure

2.6

10.7

295

D09

ICPC

Nausea

1.5

10.6

313

2052

L04AA13

ATC

leflunomide; oral

2.0

10.6

140

721

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

1.4

10.6

458

3259

GD1UN

NOMESCO Finland

Lung circulation SPECT

3.7

10.6

118

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

10.6

2860

25578

J15.8

ICD-10 Finland

Other bacterial pneumonia

3.2

10.6

165

U14

ICPC

Kidney symptom/complaint

2.4

10.6

341

R06.4

ICD-10 Finland

Hyperventilation

2.1

10.6

118

572

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.4

10.5

559

4126

D64.8

ICD-10 Finland

Other specified anaemias

2.3

10.5

391

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

2.3

10.5

392

J01DA06

ATC

[U] cefuroxime; systemic

1.3

10.5

891

7064

U08

ICPC

Urinary retention

2.2

10.5

443

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

2.4

10.5

362

R29

ICPC

Respiratory symptom/complaint other

1.5

10.5

381

2619

J11.1

ICD-10 Finland

Influenza with other respiratory manifestations, virus not identified

1.9

10.5

139

720

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.5

10.5

314

2071

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

3.4

10.5

140

J128, U071

ICD-10 Finland

+∞

10.4

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

2.8

10.4

240

-31

ICPC

Medical examin/health eval partial

1.4

10.4

444

3156

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.5

10.4

397

2759

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

5.4

10.4

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.4

10.4

474

3409

M70.6

ICD-10 Finland

Trochanteric bursitis

1.4

10.4

592

4427

A02BC03

ATC

lansoprazole; oral

1.2

10.4

1697

14502

SPF00

NOMESCO Finland

Repatation of teeth prosthesis

1.9

10.3

140

730

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.2

10.3

104

482

C09CA06

ATC

candesartan; oral

1.2

10.3

1207

9950

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.3

10.3

627

4733

M01AE02

ATC

naproxen; oral, rectal

1.2

10.3

4136

38125

C09CA01

ATC

losartan; oral

1.2

10.3

1244

10294

Z71.9

ICD-10 Finland

Counselling, unspecified

1.5

10.3

352

2392

N05AA01

ATC

chlorpromazine; systemic, rectal

2.4

10.3

364

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

1.8

10.2

156

851

G30.1

ICD-10 Finland

Alzheimer disease with late onset

1.7

10.2

214

1287

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

5.5

10.2

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

2.8

10.2

237

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

1.9

10.2

153

829

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

1.9

10.2

139

729

R32

ICD-10 Finland

Unspecified urinary incontinence

1.9

10.2

141

744

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.4

10.1

411

2891

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.4

10.1

498

3631

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.4

10.1

411

2892

K59.1

ICD-10 Finland

Functional diarrhoea

1.6

10.1

284

1844

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.8

10.1

162

898

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.8

10.1

160

883

L02

ICPC

Back symptom/complaint

1.4

10.1

580

4342

S81.9

ICD-10 Finland

Open wound of lower leg, part unspecified

3.0

10.1

188

H03AA01

ATC

levothyroxine sodium; systemic

1.2

10.1

1377

11548

SPAT1097

SPAT

Recording of ECG

1.3

10.1

804

6320

R03AC12

ATC

salmeterol; inhalant

1.6

10.1

231

1427

N04BC05

ATC

pramipexole; oral

1.5

10.1

370

2551

Q61.2

ICD-10 Finland

Polycystic kidney, autosomal dominant

3.6

10.0

119

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.6

10.0

250

1579

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

2.6

10.0

274

F43.1

ICD-10 Finland

Post-traumatic stress disorder

1.8

9.9

172

978

J96.1

ICD-10 Finland

Chronic respiratory failure

2.2

9.9

101

471

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.1

9.9

106

506

J98.0

ICD-10 Finland

Diseases of bronchus, not elsewhere classified

4.7

9.9

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.4

9.8

417

2960

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

3.9

9.8

101

1512

Kela drug reimbursment

Ibrutinib

12.2

9.8

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.4

9.8

499

3661

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.4

9.8

500

3669

S70.0

ICD-10 Finland

Contusion of hip

1.7

9.8

185

1079

GDG10

NOMESCO Finland

Bilateral transplantation of lung

8.1

9.8

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.3

9.8

784

6163

F43.0

ICD-10 Finland

Acute stress reaction

1.5

9.8

300

1988

-48

ICPC

Clarification/discussion RFE/demand

1.7

9.8

199

1188

SPAT1281

SPAT

Other administrative function

1.4

9.8

514

3792

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

7.0

9.8

GD1BT

NOMESCO Finland

Biopsy of lung with X-ray guidance

10.6

9.8

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.5

9.7

277

1807

H57.1

ICD-10 Finland

Ocular pain

1.7

9.7

188

1104

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.1

9.7

104

494

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

2.2

9.7

449

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

1.7

9.7

186

1091

C07AA05

ATC

propranolol; systemic

1.2

9.7

1234

10267

K10.3

ICD-10 Finland

Alveolitis of jaws

1.5

9.7

281

1841

K65.0

ICD-10 Finland

Acute peritonitis

2.6

9.7

251

N05AX12

ATC

aripiprazole; systemic

1.6

9.7

262

1686

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

2.9

9.7

192

H53.2

ICD-10 Finland

Diplopia

1.8

9.7

164

927

XF402

NOMESCO Finland

ECG with work load test

1.4

9.7

568

4266

IHA10

NOMESCO Finland

Structured mapping of problematic alcohol use

3.6

9.6

118

R04.0

ICD-10 Finland

Epistaxis

1.5

9.6

366

2540

N18

ICD-10 Finland

Chronic kidney disease

2.9

9.6

193

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.3

9.6

762

5987

WX725

NOMESCO Finland

Noninvasive ventilation

1.6

9.6

255

1638

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

4.1

9.6

O21.9

ICD-10 Finland

Vomiting of pregnancy, unspecified

2.1

9.5

100

471

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

1.8

9.5

157

879

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

2.1

9.5

102

485

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.6

9.4

245

1561

WW400

NOMESCO Finland

Plasmaferesis

5.5

9.3

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

1.7

9.3

184

1090

OAB72

NOMESCO Finland

Weight control and weight loss guidance

3.0

9.3

165

Z39.0

ICD-10 Finland

Care and examination immediately after delivery

2.2

9.3

405

H26.3

ICD-10 Finland

Drug-induced cataract

3.5

9.3

122

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

1.5

9.3

276

1817

N06DX01

ATC

memantine; oral

1.6

9.3

248

1593

D06

ICPC

Abdominal pain localized other

1.4

9.3

496

3672

WX203

NOMESCO Finland

Infraclavicular plexus blockade

1.9

9.2

133

710

M10.3

ICD-10 Finland

Gout due to impairment of renal function

4.2

9.2

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.0

9.2

115

585

N06AA09

ATC

amitriptyline; systemic

1.4

9.2

510

3796

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.4

9.2

362

2531

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

2.5

9.2

284

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.4

9.2

391

2779

K65.8

ICD-10 Finland

Other peritonitis

5.4

9.2

L01

ICPC

Neck symptom/complaint

1.3

9.2

841

6735

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.6

9.2

215

1339

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

1.7

9.2

195

1183

C08CA02

ATC

felodipine; oral

1.4

9.1

439

3189

1XC02

NOMESCO Finland

3.1

9.1

156

J04.0

ICD-10 Finland

Acute laryngitis

1.6

9.1

218

1363

K78

ICPC

Atrial fibrillation/flutter

1.4

9.1

363

2546

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.0

9.1

117

600

6BA02

NOMESCO Finland

4.3

9.1

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.4

9.0

523

3920

G72.8

ICD-10 Finland

Other specified myopathies

2.3

9.0

336

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.2

9.0

2210

19553

5AB14

NOMESCO Finland

5.6

9.0

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

2.6

9.0

245

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.2

9.0

1653

14261

F32.1

ICD-10 Finland

Moderate depressive episode

1.4

9.0

369

2603

R03AC03

ATC

terbutaline; inhalant

1.3

9.0

851

6843

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

3.7

9.0

100

F29

ICPC

Eye symptom/complaint other

1.4

8.9

483

3580

JN6AD

NOMESCO Finland

CT of torso and neck

2.4

8.9

302

T74.1

ICD-10 Finland

Physical abuse

1.9

8.9

130

699

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

1.8

8.9

157

903

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

1.8

8.9

157

903

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

1.7

8.8

178

1062

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.5

8.8

307

2097

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

2.3

8.8

355

R06AX27

ATC

desloratadine; oral

1.2

8.8

1856

16207

P01

ICPC

Feeling anxious/nervous/tense

1.3

8.8

795

6350

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.5

8.8

278

1858

XQ800

NOMESCO Finland

Prick test

1.4

8.8

482

3585

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.6

8.8

241

1559

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.6

8.8

225

1431

390

Kela drug reimbursment

Ibrutinib

9.5

8.8

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.4

8.7

399

2872

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.1

8.7

438

WX204

NOMESCO Finland

Axillary plexus blockaced

1.7

8.7

171

1014

OAB47

SPAT

0.4

8.7

786

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

8.6

1950

17127

Z24.6

ICD-10 Finland

Need for immunization against viral hepatitis

2.9

8.6

173

XA800

NOMESCO Finland

Neuropsychological investigation

1.6

8.6

233

1504

TKC22

NOMESCO Finland

Catheterisation instruction

1.9

8.6

114

595

D07AC13

ATC

mometasone; topical

1.2

8.6

1798

15689

U13

ICPC

Bladder symptom/complaint other

1.7

8.6

163

954

B86

ICD-10 Finland

Scabies

1.9

8.6

118

625

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

1.6

8.6

226

1449

EBA05

SPAT

2.3

8.6

316

JAH01

NOMESCO Finland

Laparoscopy

1.5

8.5

263

1748

F20.0

ICD-10 Finland

Paranoid schizophrenia

2.8

8.5

181

FP1C5

NOMESCO Finland

Resting ECG, 15 leads

2.9

8.5

175

SBB00

NOMESCO Finland

Fotograf of mouth and teeth

1.5

8.5

249

1637

T86.1

ICD-10 Finland

Kidney transplant failure and rejection

9.0

8.5

SPF30

NOMESCO Finland

Soling for prothesis

2.1

8.5

462

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.4

8.5

416

3036

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.2

8.5

1158

9704

I25

ICD-10 Finland

Chronic ischaemic heart disease

1.6

8.5

222

1419

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

1.8

8.5

150

863

P18

ICPC

Medication abuse

2.9

8.5

169

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

1.6

8.5

225

1444

L16

ICPC

Ankle symptom/complaint

1.3

8.5

620

4819

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.4

8.4

359

2554

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.2

8.4

1209

10177

A05AA02

ATC

ursodeoxycholic acid; oral

2.0

8.4

108

555

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.6

8.4

231

1497

ZZA00

NOMESCO Finland

Split skin graft

1.8

8.4

149

856

TQW80

NOMESCO Finland

Local dermatologic skincare

1.7

8.4

151

874

ZX100

NOMESCO Finland

Oral

2.2

8.4

377

NHQ40

NOMESCO Finland

Amputation of toe

2.1

8.3

412

C01CA24

ATC

epinephrine; parenteral

1.4

8.3

392

2838

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

1.5

8.3

265

1774

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.0

8.3

107

551

N05AB03

ATC

perphenazine; systemic, rectal

1.6

8.3

196

1221

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.3

8.3

627

4891

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

1.8

8.3

125

682

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

1.5

8.2

235

1535

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.0

8.2

100

504

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.5

8.2

238

1559

TK824

NOMESCO Finland

Replacement of peritoneal dialysis catheter extension tube

7.0

8.2

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

8.2

2744

24829

SAA04

NOMESCO Finland

Special inverstigation of mouth

1.4

8.2

346

2456

IGY02

NOMESCO Finland

Psychiatric monitoring contact

1.7

8.2

151

879

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

2.6

8.2

228

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

1.9

8.2

119

642

D82

ICPC

Teeth/gum disease

1.2

8.2

2473

22208

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.3

8.2

594

4609

A07EC01

ATC

sulfasalazine; oral, rectal

1.4

8.2

449

3338

T82

ICPC

Obesity

1.6

8.2

214

1369

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.5

8.2

281

1916

S02.51

ICD-10 Finland

Fracture of tooth, open

1.3

8.2

544

4171

R03DA04

ATC

theophylline; systemic, rectal

1.5

8.2

236

1549

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

4.9

8.2

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

1.9

8.2

106

549

KBV00

NOMESCO Finland

Insertion of stent into ureter

3.0

8.1

147

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

2.3

8.1

296

N73.9

ICD-10 Finland

Female pelvic inflammatory disease, unspecified

1.9

8.1

106

551

ZX114

NOMESCO Finland

Intramuscular

2.0

8.1

487

TJA33

NOMESCO Finland

Percutaneous introduction of peritoneal dialysis catheter

5.7

8.1

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

2.6

8.1

216

K02.9

ICD-10 Finland

Dental caries, unspecified

2.0

8.1

103

528

AN1

Coronary angiography

1.3

8.1

573

4434

C02AC05

ATC

moxonidine; oral

1.6

8.1

216

1390

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.5

8.1

236

1552

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

2.1

8.0

406

G20

ICD-10 Finland

Parkinson disease

1.8

8.0

138

785

J05AB11

ATC

valaciclovir; oral

1.3

8.0

752

6039

B03XA01

ATC

erythropoietin; parenteral

2.7

8.0

187

Z72.2

ICD-10 Finland

Drug use

2.7

8.0

187

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

4.3

8.0

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

1.6

8.0

199

1259

A07EA06

ATC

budesonide; oral, local oral

1.6

7.9

191

1200

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

1.9

7.9

117

636

K03.64

ICD-10 Finland

Dental calculus supragingival

1.2

7.9

1952

17247

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.3

7.9

729

5838

XG474

NOMESCO Finland

Exhalation nntrogen oxide

1.7

7.9

164

991

K05.31

ICD-10 Finland

Periodontitis pronounced

1.3

7.9

476

3594

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

1.6

7.9

192

1210

R20.2

ICD-10 Finland

Paraesthesia of skin

1.4

7.9

388

2834

L50.9

ICD-10 Finland

Urticaria, unspecified

1.6

7.9

217

1407

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

1.5

7.9

258

1740

J01MA06

ATC

norfloxacin; oral

1.3

7.9

727

5823

Y94.8

ICD-10 Finland

Other leisure activity accident

1.7

7.9

151

890

D07AB02

ATC

hydrocortisone butyrate; topical

1.2

7.9

1782

15642

M03BX01

ATC

baclofen; systemic

2.0

7.8

453

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

3.6

7.8

R5140

SPAT

3.8

7.8

XF602

NOMESCO Finland

Bloodpressure monitoring

2.4

7.8

260

B99

ICD-10 Finland

Other and unspecified infectious diseases

1.9

7.8

101

523

L15

ICPC

Knee symptom/complaint

1.2

7.8

1191

10093

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

1.8

7.8

119

653

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

1.9

7.8

115

625

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

2.1

7.8

377

R41.3

ICD-10 Finland

Other amnesia

1.8

7.8

136

782

H01.0

ICD-10 Finland

Blepharitis

1.4

7.7

313

2206

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.3

7.7

511

3911

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

1.7

7.7

152

904

SGA01

NOMESCO Finland

Tooth opening as first aid

1.2

7.7

1014

8457

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.6

7.7

172

1056

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

2.2

7.7

345

M79.7

ICD-10 Finland

Fibromyalgia

1.6

7.7

182

1136

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

3.6

7.7

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

1.8

7.7

134

769

J18.2

ICD-10 Finland

Hypostatic pneumonia, unspecified

15.0

7.7

L01EL01

ATC

ibrutinib; oral

15.0

7.7

M86.8

ICD-10 Finland

Other osteomyelitis

6.3

7.7

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

1.6

7.7

175

1084

O68.8

ICD-10 Finland

Labour and delivery complicated by other evidence of fetal stress

2.3

7.7

275

J32.9

ICD-10 Finland

Chronic sinusitis, unspecified

2.3

7.7

286

S09.9

ICD-10 Finland

Unspecified injury of head

2.2

7.7

327

L13

ICPC

Hip symptom/complaint

1.3

7.7

787

6390

PB1AC

NOMESCO Finland

Angiography of upper extremity with X-ray

7.4

7.7

GD1LA

NOMESCO Finland

2.2

7.6

348

HAHOM

NOMESCO Finland

2.0

7.6

443

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

3.2

7.6

115

XX9TE

NOMESCO Finland

Compementary ultrasound examination

2.8

7.6

159

SBA00

NOMESCO Finland

Microbiological examinations

1.8

7.6

124

697

R52.2

ICD-10 Finland

Other chronic pain

1.6

7.6

181

1133

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

1.8

7.6

129

732

Z94.1

ICD-10 Finland

Heart transplant status

4.3

7.6

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

1.6

7.6

200

1285

SPAT1304

SPAT

Counselling and guidance related to ageing

1.4

7.6

301

2114

L84

ICD-10 Finland

Corns and callosities

1.6

7.6

171

1058

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.2

7.6

888

7319

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

2.3

7.6

290

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.2

7.5

1176

9980

SPAT1060

SPAT

Administration of oxygen

3.5

7.5

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

4.5

7.5

Z94.4

ICD-10 Finland

Liver transplant status

3.8

7.5

L29.9

ICD-10 Finland

Pruritus, unspecified

1.8

7.5

130

745

IAB10

NOMESCO Finland

Psychiatric consultation concerning substance abuse

5.7

7.5

WZA90

NOMESCO Finland

Other doctors statement

1.2

7.5

1536

13361

P06

ICPC

Sleep disturbance

1.3

7.5

594

4667

IGY99

NOMESCO Finland

Other psychiatric treatment contact

1.8

7.5

126

714

I95.9

ICD-10 Finland

Hypotension, unspecified

2.2

7.5

345

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

2.1

7.5

358

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

1.7

7.5

144

852

D07AB08

ATC

desonide; topical

1.3

7.5

633

5019

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

2.8

7.4

156

EBA10

NOMESCO Finland

Surgical removal of tooth

1.2

7.4

903

7471

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

2.2

7.4

338

A40.8

ICD-10 Finland

Other streptococcal sepsis

2.6

7.4

186

K50.8

ICD-10 Finland

Other Crohn disease

2.0

7.4

484

C83.1

ICD-10 Finland

Mantle cell lymphoma

3.8

7.4

QDH05

NOMESCO Finland

Correction of deformity of toe nail

3.8

7.4

B01AB04

ATC

dalteparin; parenteral

1.5

7.4

248

1681

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.3

7.4

486

3717

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

2.4

7.4

248

F10.24

ICD-10 Finland

Alcohol depence active use

2.0

7.4

422

H91.9

ICD-10 Finland

Hearing loss, unspecified

1.6

7.4

201

1304

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

7.4

2291

20589

GX1K5

NOMESCO Finland

Diffusion capacity

5.3

7.4

RS220

NOMESCO Finland

2.1

7.4

401

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

2.2

7.3

332

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

1.8

7.3

125

713

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.2

7.3

1298

11145

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

2.4

7.3

242

L08.0

ICD-10 Finland

Pyoderma

2.4

7.3

242

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.3

7.3

599

4729

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

2.1

7.3

381

N06DA02

ATC

donepezil; oral

1.6

7.3

201

1305

I44.2

ICD-10 Finland

Atrioventricular block, complete

1.8

7.3

115

641

F00.20*G30.8

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

2.2

7.3

336

T14.0

ICD-10 Finland

Superficial injury of unspecified body region

2.1

7.3

348

SPAT1325

SPAT

Vaccination

1.2

7.3

2203

19761

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.4

7.2

285

1999

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

1.6

7.2

164

1016

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.5

7.2

222

1478

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

1.6

7.2

199

1292

GBB00

NOMESCO Finland

Tracheostomy

2.3

7.2

275

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

1.5

7.2

211

1389

TQW99

NOMESCO Finland

Other minor procedure on skin

1.5

7.2

241

1635

WX610

NOMESCO Finland

Patient controlled analgesia

2.6

7.2

184

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

2.3

7.2

276

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.3

7.2

415

3115

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

1.6

7.2

160

986

K02.8

ICD-10 Finland

Other dental caries

1.7

7.2

141

837

EBA30

NOMESCO Finland

Excision of root of tooth

1.4

7.2

277

1936

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

2.4

7.2

239

N29

ICPC

Neurological sympt/complt other

1.9

7.2

100

534

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.5

7.1

258

1780

N03AF01

ATC

carbamazepine; oral, rectal

1.5

7.1

258

1781

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

1.8

7.1

123

704

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

2.5

7.1

203

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.3

7.1

585

4620

U10.9

ICD-10 Finland

Multisystem inflammatory syndrome associated with COVID-19, unspecified

20.0

7.1

J47

ICD-10 Finland

Bronchiectasis

2.0

7.1

442

B01AF01

ATC

rivaroxaban; oral

1.3

7.1

547

4281

K04.08

ICD-10 Finland

Other specified pulpit

1.4

7.1

407

3049

L18

ICPC

Muscle pain

1.5

7.1

207

1365

S01

ICPC

Pain/tenderness of skin

1.5

7.1

228

1535

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

2.0

7.1

416

G93.3

ICD-10 Finland

Postviral fatigue syndrome

3.2

7.1

111

FQA10

NOMESCO Finland

Orthotopic transplantation of heart with bicaval anastomosis

7.9

7.1

L09

ICPC

Arm symptom/complaint

1.5

7.1

241

1643

A07AA02

ATC

nystatin; oral

1.4

7.1

308

2205

I80.9

ICD-10 Finland

Phlebitis and thrombophlebitis of unspecified site

2.1

7.1

359

S90.3

ICD-10 Finland

Contusion of other and unspecified parts of foot

1.7

7.1

142

853

H66.9

ICD-10 Finland

Otitis media, unspecified

1.4

7.0

381

2832

R4160

SPAT

10.0

7.0

JA3FT

NOMESCO Finland

Exchange abdominal catheter with radiological guidance

10.0

7.0

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.4

7.0

293

2080

J01.1

ICD-10 Finland

Acute frontal sinusitis

1.9

7.0

504

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.0

7.0

452

N06AB03

ATC

fluoxetine; oral

1.3

7.0

715

5802

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

2.6

7.0

182

FN2AB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), drug-eluting balloon

2.2

7.0

308

R15

ICD-10 Finland

Faecal incontinence

1.8

7.0

116

658

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.6

6.9

164

1025

F05.8

ICD-10 Finland

Other delirium

2.8

6.9

146

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

1.9

6.9

511

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.5

6.9

252

1741

ED1AA

NOMESCO Finland

Mandipular X-ray examination

2.7

6.9

159

A23

ICPC

Risk factor NOS

1.3

6.9

512

3987

K92.0

ICD-10 Finland

Haematemesis

1.7

6.9

121

697

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.3

6.9

527

4120

D02

ICPC

Abdominal pain epigastric

1.4

6.9

321

2327

H53.1

ICD-10 Finland

Subjective visual disturbances

1.4

6.9

322

2332

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.5

6.9

233

1589

T78.4

ICD-10 Finland

Allergy, unspecified

1.4

6.9

279

1972

N45.9

ICD-10 Finland

Orchitis, epididymitis and epididymo-orchitis without abscess

1.8

6.9

108

602

B35.3

ICD-10 Finland

Tinea pedis

1.5

6.9

215

1441

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

1.4

6.9

280

1978

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.2

6.9

830

6864

R03AC13

ATC

formoterol; inhalant

1.5

6.9

250

1730

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.0

6.9

448

K90

ICPC

Stroke/cerebrovascular accident

1.7

6.8

131

774

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

1.6

6.8

150

922

R5430

NOMESCO Finland

Interpreter's services

3.9

6.8

M87.9

ICD-10 Finland

Osteonecrosis, unspecified

3.3

6.8

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

3.0

6.8

120

I50.1

ICD-10 Finland

Left ventricular failure

1.5

6.8

196

1290

K02.2

ICD-10 Finland

Caries of cementum

1.5

6.8

211

1413

WX199

NOMESCO Finland

Other local analgesia

1.7

6.8

125

731

I20.90

ICD-10 Finland

Angina pectoris, unspecified

1.6

6.8

159

994

N20.0

ICD-10 Finland

Calculus of kidney

1.8

6.8

114

649

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.6

6.7

147

900

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.1

6.7

2777

25416

SPAT1377

SPAT

Polysomnography

1.6

6.7

181

1172

CL2S4

SPAT

2.9

6.7

127

W90

ICPC

Uncompl labour/delivery livebirth

1.4

6.7

299

2149

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.5

6.7

207

1382

A10BK01

ATC

dapagliflozin; oral

1.5

6.7

210

1407

S10

ICPC

Boil/carbuncle

1.4

6.7

303

2182

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.0

6.7

391

D07AA02

ATC

hydrocortisone; topical

1.2

6.7

892

7448

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

3.0

6.7

116

JJC00

NOMESCO Finland

Allogenic transplantation of liver

4.3

6.7

329

Kela drug reimbursment

Lenalidomide

4.3

6.7

K85

ICPC

Elevated blood pressure

1.2

6.7

702

5716

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.3

6.7

504

3938

R07.1

ICD-10 Finland

Chest pain on breathing

1.9

6.7

434

F32

ICD-10 Finland

Depressive episode

1.4

6.7

335

2459

C07AG02

ATC

carvedilol; oral

1.4

6.6

270

1909

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.3

6.6

473

3663

Z93

ICD-10 Finland

Artificial opening status

3.8

6.6

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

3.0

6.6

117

R01AD01

ATC

beclometasone; nasal

1.2

6.6

883

7375

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.4

6.6

296

2128

N18.4

ICD-10 Finland

Chronic kidney disease, stage 4

5.9

6.6

AA3AD

NOMESCO Finland

CT of face

2.7

6.6

146

Z13.9

ICD-10 Finland

Special screening examination, unspecified

3.0

6.6

112

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.3

6.6

422

3219

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

2.2

6.6

284

SGA03

NOMESCO Finland

Demanding opening and dilatation of root canal of tooth

1.3

6.6

572

4554

TK823

NOMESCO Finland

Peritoneal permeability analysis

12.2

6.6

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

0.1

6.6

222

WYA30

SPAT

2.9

6.6

133

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

1.9

6.6

500

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.3

6.6

668

5421

NOMESCO Finland

Other rehabilitation services

8.7

6.5

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.3

6.5

416

3170

SPAT1153

SPAT

Removal of sutures

1.2

6.5

1895

16926

W10

ICD-10 Finland

Fall on and from stairs and steps

1.4

6.5

263

1859

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.3

6.5

412

3136

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

1.7

6.5

133

800

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

2.2

6.5

278

SPAT1360

SPAT

Extensive global examination

1.3

6.5

405

3082

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

1.6

6.5

156

985

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

2.0

6.4

348

R5130

SPAT

6.2

6.4

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.2

6.4

721

5914

T89

ICPC

Diabetes insulin dependent

1.5

6.4

236

1635

S06

ICPC

Rash localized

1.4

6.4

302

2193

GD1RA

NOMESCO Finland

Dynamic X-ray examination of respiratory organs with convetional X-ray picture

5.3

6.4

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.4

6.4

337

2492

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

2.3

6.4

239

N06AB06

ATC

sertraline; oral

1.2

6.4

669

5442

I95.2

ICD-10 Finland

Hypotension due to drugs

2.8

6.4

136

A10AE06

ATC

insulin degludec; parenteral

1.6

6.4

173

1123

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

2.3

6.4

229

A08.5

ICD-10 Finland

Other specified intestinal infections

2.9

6.4

120

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

2.4

6.4

210

Y96.9

ICD-10 Finland

Unspecified type of accident

1.8

6.4

543

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

2.7

6.4

143

C08CA13

ATC

lercanidipine; oral

1.3

6.4

604

4857

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

1.9

6.4

499

Z43.5

ICD-10 Finland

Attention to cystostomy

3.2

6.4

J86.9

ICD-10 Finland

Pyothorax without fistula

2.5

6.4

192

N03AX14

ATC

levetiracetam; systemic

1.7

6.4

135

821

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

1.5

6.4

231

1600

F29

ICD-10 Finland

Unspecified nonorganic psychosis

1.5

6.4

235

1629

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

1.6

6.4

153

963

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.4

6.4

306

2231

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.4

6.3

314

2299

R25.1

ICD-10 Finland

Tremor, unspecified

1.6

6.3

138

846

Z32.1

ICD-10 Finland

Pregnancy confirmed

1.3

6.3

620

5007

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.5

6.3

198

1328

TNX99

NOMESCO Finland

Other orthopaedic minor procedure

1.6

6.3

148

926

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

2.3

6.3

243

H26.4

ICD-10 Finland

After-cataract

1.3

6.3

375

2827

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

1.7

6.3

121

717

K02

ICD-10 Finland

Dental caries

1.3

6.3

414

3171

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

2.4

6.3

212

H60.8

ICD-10 Finland

Other otitis externa

1.6

6.3

151

949

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.4

6.3

335

2482

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

1.7

6.3

128

773

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

1.9

6.3

493

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

1.7

6.3

121

720

P02

ICPC

Acute stress reaction

1.4

6.3

268

1911

NG1DA

NOMESCO Finland

X-ray of knees

1.9

6.3

465

399

Kela drug reimbursment

Venetoclax

11.0

6.3

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

4.2

6.3

U29

ICPC

Urinary symptom/complaint other

1.6

6.3

134

817

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

1.5

6.3

209

1419

SPAT1139

SPAT

Nutrition survey

1.5

6.3

176

1153

H60

ICD-10 Finland

Otitis externa

1.4

6.3

265

1889

M02AA07

ATC

piroxicam; topical

1.1

6.3

2070

18652

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

1.8

6.3

525

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.4

6.3

329

2433

304

Kela drug reimbursment

Dornase alfa

18.0

6.3

R05CB13

ATC

dornase alfa (desoxyribonuclease); inhalant

18.0

6.3

SPE90

NOMESCO Finland

Other fitting and preparation of partial tooth prosthesis

1.8

6.3

104

591

R23

ICPC

Voice symptom/complaint

1.7

6.2

120

712

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.4

6.2

319

2351

J31.0

ICD-10 Finland

Chronic rhinitis

1.3

6.2

430

3319

N25.0

ICD-10 Finland

Renal osteodystrophy

4.3

6.2

K91

ICPC

Cerebrovascular disease

2.1

6.2

304

I80.0

ICD-10 Finland

Phlebitis and thrombophlebitis of superficial vessels of lower extremities

1.5

6.2

178

1170

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

1.6

6.2

133

813

D04.6

ICD-10 Finland

Carcinoma in situ: Skin of upper limb, including shoulder

3.0

6.2

112

Z51.5

ICD-10 Finland

Palliative care

1.4

6.2

258

1837

J20.8

ICD-10 Finland

Acute bronchitis due to other specified organisms

3.5

6.2

WKEHK

NOMESCO Finland

5.0

6.2

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

1.5

6.2

225

1558

P19

ICPC

Drug abuse

2.1

6.2

319

Z29

ICPC

Social problem NOS

1.7

6.1

119

708

PB1BC

NOMESCO Finland

Extensive angiography of upper extremity with X-ray

5.7

6.1

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

2.2

6.1

274

SGC00

NOMESCO Finland

Local medication of root channels of tooth

1.2

6.1

642

5229

O28.8

ICD-10 Finland

Other abnormal findings on antenatal screening of mother

2.0

6.1

333

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

2.2

6.1

254

L04AB05

ATC

certolizumab pegol; parenteral

2.9

6.1

113

N20.1

ICD-10 Finland

Calculus of ureter

1.5

6.1

195

1315

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

1.9

6.1

440

G43.8

ICD-10 Finland

Other migraine

1.8

6.1

484

N03AF02

ATC

oxcarbazepine; oral

1.5

6.1

174

1147

N05CF02

ATC

zolpidem; oral

1.2

6.1

997

8497

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

3.0

6.1

102

IAB08

NOMESCO Finland

Consultation concerning a patient who has attempted suicide

3.5

6.1

YHMAS

NOMESCO Finland

2.1

6.1

300

J01XB01

ATC

colistin; inhalant, parenteral

12.5

6.1

K06

ICD-10 Finland

Other disorders of gingiva and edentulous alveolar ridge

12.5

6.1

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

2.3

6.1

215

R06AX22

ATC

ebastine; oral

1.2

6.1

1009

8611

SPAT1368

SPAT

Periodic check-up in occupational healthcare

0.5

6.1

781

K57.9

ICD-10 Finland

Diverticular disease of intestine, part unspecified, without perforation or abscess

1.8

6.1

547

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

1.8

6.1

547

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

1.8

6.0

532

G04BD04

ATC

oxybutynin; oral, transdermal

1.4

6.0

238

1675

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

6.0

142

893

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

3.3

6.0

J03.8

ICD-10 Finland

Acute tonsillitis due to other specified organisms

3.3

6.0

K43

ICPC

Cardiovascular, Other diagnostic procedure

2.1

6.0

277

N64.4

ICD-10 Finland

Mastodynia

1.6

6.0

145

916

T79.3

ICD-10 Finland

Post-traumatic wound infection, not elsewhere classified

1.9

6.0

388

N87

ICPC

Parkinsonism

2.2

6.0

269

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

2.2

6.0

257

B82

ICPC

Anaemia other/unspecified

1.7

6.0

113

669

J01DC02

ATC

cefuroxime; systemic

1.4

6.0

329

2451

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3023103) Potassium [Moles/volume] in Serum or Plasma

12528

108167

4.39

320.07

37.2

15.4

4.0

mmol/l

2.44

12401

105063

(3042936) Bacteria identified in Isolate by Culture

2956

14565

2.33

318.35

2.7

2.0

—

(1616796) Gas panel - Central venous blood

903

2293

4.15

316.39

5.1

3.4

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

3387

15722

2.55

307.65

3.3

2.1

30.1

29.9

1.32

3312

15215

(3006315) Basophils [#/volume] in Blood

9008

53085

3.21

307.65

9.3

5.7

0.0

e9/l

24.21

7685

45938

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

6411

41891

2.03

307.65

2.4

1.9

92.0

95.5

pmol/l

8.42

3807

22335

(3003458) Phosphate [Moles/volume] in Serum or Plasma

3125

13217

2.79

307.65

10.8

5.6

1.1

1.0

mmol/l

6.87

2997

12290

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

3274

14223

2.73

307.65

3.8

2.5

21.1

22.7

7.69

2806

12077

(3012544) pH of Venous blood

2611

9411

3.21

307.65

6.6

4.0

7.4

0.01

(3002030) Lymphocytes/100 leukocytes in Blood

8827

51446

3.18

307.65

9.8

5.9

25.2

28.2

104.26

8544

47835

(3002173) Hemoglobin [Mass/volume] in Arterial blood

2824

9226

3.62

307.65

12.6

7.7

120.7

121.4

g/l

1.06

2767

8871

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1976

6563

3.37

307.65

6.1

3.7

5.1

kpa

2.23

1847

6067

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

4574

10819

5.95

307.65

2.4

1.7

—

(3021901) Oxygen saturation in Capillary blood

900

1775

5.37

307.65

4.1

2.6

—

(36304419) Bacteria [Presence] in Urine

5423

28611

2.52

307.65

4.7

3.0

—

(3000850) Epithelial cells [#/volume] in Urine

4257

22382

2.33

307.65

3.7

2.5

5.8

5.7

e6/l

0.32

3778

19530

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

10924

79913

3.17

307.65

12.5

7.1

79.9

77.6

u/l

6.07

10614

75097

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1719

5110

3.72

307.65

16.1

8.8

24.6

24.2

mmol/l

5.39

1624

4759

(3002385) Erythrocyte distribution width [Ratio]

11272

89522

2.82

307.65

36.6

16.0

13.9

13.6

54.42

11160

87620

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2012

6238

3.63

307.65

10.7

7.3

24.9

24.7

mmol/l

1.54

2002

6189

(3021440) Promyelocytes/100 leukocytes in Blood

2157

8093

2.99

307.65

5.7

4.0

0.1

0.66

831

2105

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1555

4923

3.45

307.65

6.9

4.3

24.3

24.0

mmol/l

2.05

1444

4409

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

12724

107811

6.67

307.65

32.6

13.3

26.6

23.6

mg/l

24.69

11951

84963

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1823

6170

3.27

307.65

16.1

8.5

1.2

1.4

12.65

1817

6129

(3000991) Gas panel - Venous blood

2528

8446

3.47

307.65

15.3

7.9

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

3347

5467

7.87

307.65

2.1

1.6

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

8777

53236

2.95

307.65

9.3

5.8

10.9

11.7

umol/l

7.71

8490

50219

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

3829

16325

2.90

307.65

4.2

2.8

3.1

2.7

e6/l

1.33

2035

8783

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2568

9107

3.26

307.65

6.7

3.9

5.8

kpa

0.33

2510

8815

(3030467) Casts [#/volume] in Urine by Automated count

5605

29140

2.61

307.65

4.8

3.1

0.4

e6/l

0.16

4184

21933

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

6616

42838

2.10

307.65

2.8

2.2

74.7

76.2

nmol/l

3.79

6118

38622

(3037467) Urinalysis macro (dipstick) panel - Urine

10104

74318

2.55

307.65

6.5

4.2

—

(3023520) Reticulocytes [#/volume] in Blood

2136

8533

2.79

307.65

3.5

2.5

70.8

69.0

e9/l

1.19

1450

6457

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

3221

11299

3.45

307.65

11.7

6.9

5.0

5.1

kpa

3.76

3142

10732

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

5362

32558

2.09

307.65

3.6

2.5

57.4

57.9

u/l

0.13

5031

29999

(3006504) Eosinophils/100 leukocytes in Blood

8695

49566

3.23

307.65

9.7

5.8

2.3

2.9

88.91

8401

46071

(40767503) Oxygen content in Capillary blood by calculation

936

2127

4.66

307.65

3.9

2.3

16.0

16.4

1.71

684

1040

(3026782) Osmolality of Urine

4015

20434

2.39

307.65

3.8

2.7

527.8

549.0

mosm/kgh2o

7.70

3535

17341

(3002179) Metamyelocytes/100 leukocytes in Blood

2065

7747

2.98

307.65

5.1

3.8

0.7

0.6

0.90

672

1643

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1000

2275

4.67

307.65

3.2

2.1

127.1

129.6

g/l

2.02

811

1660

(3002582) Erythrocytes [#/volume] in Urine

6211

31807

2.81

307.65

5.0

3.1

102.9

89.9

e6/l

0.18

4818

24376

(3014111) Lactate [Moles/volume] in Serum or Plasma

2807

8675

3.84

307.65

12.2

6.6

1.3

1.4

mmol/l

1.71

2709

8321

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

4607

10747

6.06

307.65

2.4

1.6

—

(3018418) pH of Serum or Plasma

5442

29872

2.40

307.65

7.0

3.9

7.4

0.99

1227

5792

(3014576) Chloride [Moles/volume] in Serum or Plasma

3155

12287

3.06

307.65

12.8

6.8

104.2

104.5

mmol/l

3.02

3041

12028

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1426

2976

5.25

307.65

3.6

2.6

4.3

3.5

g/l

45.18

1393

2804

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

3527

11424

3.85

307.65

4.7

4.1

250.5

243.7

u/l

1.53

3423

10718

(3021601) Nitrite [Presence] in Urine by Test strip

7899

52571

2.26

307.65

6.7

4.7

0.0

estimate

0.07

2046

10273

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

4858

27357

2.23

307.65

2.8

2.2

2.9

mg/l

0.29

4273

23349

(3016502) Oxygen saturation in Arterial blood

3041

10054

3.63

307.65

12.0

7.3

95.0

95.7

6.91

2981

9631

(3018095) Leukocytes [#/volume] in Urine

6804

37484

2.69

307.65

6.0

3.6

94.6

92.9

e6/l

0.06

5099

26293

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

6312

38389

2.24

307.65

5.6

3.5

77.9

70.2

ng/l

0.08

4442

25313

(3022948) Iron [Moles/volume] in Serum or Plasma

3610

16650

2.61

307.65

3.7

2.4

11.5

13.2

umol/l

29.98

3393

15360

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

7964

45976

2.86

307.65

12.2

5.8

1.2

mmol/l

58.53

7508

41578

(3021589) Normoblasts [#/volume] in Blood

8260

46297

3.11

307.65

16.7

9.2

0.0

e9/l

0.16

6728

37794

(3018010) Neutrophils/100 leukocytes in Blood

8745

50638

3.17

307.65

9.4

5.7

60.1

57.1

91.85

8476

47294

(3009261) Glucose [Presence] in Urine by Test strip

7925

53079

2.24

307.65

5.0

3.6

0.0

estimate

0.30

1980

9996

(3024561) Albumin [Mass/volume] in Serum or Plasma

7488

44465

2.59

307.65

7.6

4.7

34.0

35.6

g/l

94.83

7115

41138

(3025159) Blasts/100 leukocytes in Blood

2071

7653

3.02

307.65

5.7

4.0

0.1

0.3

1.39

739

1790

(3027945) Reticulocytes/100 erythrocytes in Blood

2690

11563

2.67

307.65

3.6

2.5

1.9

1.7

7.86

2440

10153

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

8549

50538

2.98

307.65

13.6

6.3

1.2

mmol/l

53.15

7481

42364

(3019198) Lymphocytes [#/volume] in Blood

9093

54599

3.16

307.65

9.4

5.7

1.9

e9/l

0.15

7874

48146

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1893

6269

3.36

307.65

6.0

3.7

2.2

1.6

mmol/l

10.14

1443

4550

(3013826) Glucose [Moles/volume] in Serum or Plasma

9639

61597

3.12

307.65

9.9

4.5

6.8

6.7

mmol/l

4.61

9377

56900

(3017181) Myelocytes/100 leukocytes in Blood

2289

8481

3.06

307.65

5.6

4.0

1.0

0.9

0.28

879

2268

(3028626) Oxygen [Partial pressure] in Capillary blood

1051

2516

4.45

307.65

5.7

3.7

8.2

8.4

kpa

4.54

991

2329

(3021960) Folate [Moles/volume] in Serum or Plasma

4674

23737

2.50

307.65

1.8

1.5

19.4

20.2

nmol/l

2.16

4214

20392

(3015377) Calcium [Moles/volume] in Serum or Plasma

5715

34313

2.18

307.65

4.1

3.2

2.3

2.4

mmol/l

22.94

5214

29873

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

5225

27966

2.44

307.65

4.3

3.0

1930.5

1496.5

ng/l

7.01

4705

23844

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1732

5316

3.60

307.65

14.8

9.4

—

(3013115) Eosinophils [#/volume] in Blood

9140

54885

3.18

307.65

10.1

5.9

0.2

e9/l

20.84

7876

48245

(3012095) Magnesium [Moles/volume] in Serum or Plasma

4086

16104

3.23

307.65

5.1

3.2

0.8

mmol/l

3.56

3898

14986

(3020779) Urea [Moles/volume] in Serum or Plasma

2410

9058

3.03

307.65

13.5

6.8

10.6

9.8

mmol/l

5.89

2342

8604

(3032080) INR in Blood by Coagulation assay

7192

41092

2.66

307.65

12.3

9.0

1.2

1.3

inr

7.59

2572

12038

(3019060) Gas panel - Arterial blood

1749

6535

2.93

307.65

5.4

4.8

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1052

2847

3.93

307.65

1.4

1.3

—

(3019069) Monocytes/100 leukocytes in Blood

8732

49858

3.24

307.65

10.1

6.1

8.6

1.23

8471

46595

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

4525

19283

3.05

307.65

5.5

3.6

334.3

514.1

ng/l

1.61

3635

14514

(3019550) Sodium [Moles/volume] in Serum or Plasma

12523

107867

4.42

307.65

36.7

15.3

139.1

139.6

mmol/l

84.09

12405

104994

(3022096) Basophils/100 leukocytes in Blood

8566

48022

3.25

307.65

9.7

5.9

0.5

0.7

81.54

8289

44675

(3001122) Ferritin [Mass/volume] in Serum or Plasma

8083

48855

2.70

307.65

4.0

2.9

195.2

115.0

ug/l

66.02

7660

45289

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1099

2520

4.67

307.65

4.8

3.0

24.7

24.6

mmol/l

0.16

991

2197

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2111

7326

3.24

307.65

1.9

1.6

—

(3031040) Bacteria [#/volume] in Urine by Automated count

10061

71708

2.72

307.65

6.9

4.3

1440.4

1638.6

e6/l

0.16

276

959

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1820

6159

3.27

307.65

16.2

8.6

0.6

0.7

10.64

1815

6115

(3035350) Ketones [Presence] in Urine by Test strip

7866

52497

2.24

307.65

5.0

3.5

0.0

estimate

1.54

1916

10059

(3026008) Bacteria identified in Urine by Culture

5805

31380

2.52

307.65

4.2

3.0

—

(3024354) Oxygen [Partial pressure] in Venous blood

2046

7468

3.06

307.65

5.6

3.4

4.8

4.6

kpa

4.04

1983

7202

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2364

5840

4.72

307.65

1.8

1.5

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

3739

17565

2.58

307.65

4.1

2.7

1.1

e6/l

0.30

1938

9971

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

11902

98358

3.23

307.65

28.4

12.3

81.0

83.3

ml/min/173m2

17.15

10265

80709

(3027801) Oxygen [Partial pressure] in Arterial blood

3220

11294

3.45

307.65

11.7

6.9

11.2

12.6

kpa

50.59

3136

10719

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

6271

16021

6.57

307.65

2.5

1.7

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

3445

15308

2.69

307.65

3.7

2.4

2.2

2.3

g/l

23.75

3233

14095

(3009343) pH of Capillary blood

1944

6486

3.34

307.65

6.1

3.7

7.4

5.06

521

739

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1217

3292

3.97

307.65

4.4

3.2

0.3

u/ml

0.13

605

1877

(3002032) Base excess in Venous blood by calculation

2556

9045

3.27

307.65

6.7

4.0

1.8

mmol/l

0.28

2223

7232

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2039

3638

6.45

307.65

2.3

1.9

1.3

2.4

ug/l

3.26

1797

3174

(3023368) Bacteria identified in Blood by Culture

7787

27283

5.55

307.65

6.4

4.0

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

6236

22302

4.42

307.65

2.8

1.7

1.3

1.2

mg/l

2.08

5276

16676

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

374

45.79

307.65

1.3

1.7

334.9

155.5

ng/l

0.36

258

(42870588) Differential panel, method unspecified - Blood

7250

35698

3.30

307.65

9.2

5.8

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

12202

71911

10.75

307.65

3.9

3.2

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

9631

61042

3.16

307.65

14.6

8.6

4.4

4.1

e9/l

18.55

8421

53237

(3003396) Base excess in Arterial blood by calculation

3225

11290

3.46

307.65

11.7

6.9

1.2

1.0

mmol/l

1.61

2726

8658

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

405

152

27.45

307.65

1.3

1.1

—

(3013707) Erythrocyte sedimentation rate by Westergren method

10175

78022

2.35

307.65

5.8

3.9

15.6

11.7

mm/h

86.93

9655

72177

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

5263

30590

2.20

307.65

2.8

2.1

256.2

213.5

u/l

1.75

5066

28645

(3033658) Prothrombin time (PT) actual/Normal

4832

26078

2.35

307.65

7.0

3.8

88.1

89.5

3.40

4750

25406

(3001604) Monocytes [#/volume] in Blood

8983

52814

3.21

307.65

9.3

5.7

0.6

e9/l

5.38

7671

45709

(3014007) Fractional oxyhemoglobin in Arterial blood

1795

6193

3.20

307.65

16.5

8.6

93.5

94.0

2.89

1788

6169

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

826

2009

4.32

306.30

9.3

4.9

848.0

2134.4

iu/ml

0.62

161

252

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

900

2339

4.06

305.33

2.1

1.5

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5392

33935

2.00

304.18

4.3

3.1

33.1

34.0

u/l

0.41

5133

32110

(3004119) Hemoglobin [Mass/volume] in Venous blood

1539

5714

2.92

296.30

6.0

3.4

123.9

129.1

g/l

15.41

1510

5564

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

866

2276

4.00

288.98

2.1

1.6

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1210

3977

3.25

287.65

2.5

1.8

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1866

7769

2.63

287.63

3.8

2.5

10.1

10.6

g/l

4.00

1753

7090

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

3393

18342

2.15

286.97

3.2

3.0

2.5

2.4

mmol/l

9.29

3120

15873

(40758558) Short blood count panel - Blood

4415

26309

2.02

286.93

9.7

6.7

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

672

1497

4.68

278.24

4.3

2.8

2332.9

1523.5

u/ml

0.18

(40760892) CBC W Ordered Manual Differential panel - Blood

4064

23872

2.02

272.15

6.7

4.2

—

(3015736) pH of Urine

6047

40731

1.90

268.61

4.4

3.3

5.5

5.7

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1574

6275

2.71

263.27

8.1

7.0

24.6

24.5

mmol/l

0.40

1519

5829

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

12724

113344

4.86

260.89

17.2

9.7

27.3

26.2

u/l

4.37

12470

109327

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

691

1664

4.33

258.96

1.9

1.4

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1144

3864

3.15

258.94

6.4

5.2

1.6

1.7

1.71

1111

3578

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1293

4686

2.95

258.65

2.2

1.7

1.6

1.5

g/l

3.26

1152

3982

(3007930) Methemoglobin/Hemoglobin.total in Blood

1134

3814

3.16

258.53

6.6

5.2

0.9

0.17

1103

3534

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2214

10477

2.34

256.38

4.3

3.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1232

4369

3.01

256.13

2.8

1.9

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

11544

97923

2.47

251.72

5.6

4.6

1.9

2.1

mu/l

2.02

10816

90031

(3020630) Protein [Mass/volume] in Serum or Plasma

1848

8135

2.48

251.27

3.0

2.4

64.8

66.6

g/l

16.44

1715

7346

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2065

9565

2.37

250.73

3.5

2.4

35.7

44.6

u/l

0.93

1742

8177

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

10129

82183

2.01

238.68

4.5

3.9

14.8

14.7

pmol/l

4.51

9329

74822

(3044889) 12 lead EKG panel

9092

71239

1.90

236.78

4.8

3.6

—

(3007853) Bacteria identified in Skin by Aerobe culture

2465

12605

2.18

234.62

2.3

1.7

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

665

1675

4.13

234.47

2.1

1.6

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2021

9609

2.30

229.42

2.4

2.2

364.8

378.0

nmol/l

1.88

1884

8802

(3007461) Platelets [#/volume] in Blood

13052

120047

13.84

226.55

44.1

19.7

249.4

251.3

e9/l

2.58

12861

116957

(40761511) CBC panel - Blood by Automated count

12551

112213

3.63

225.61

26.0

12.6

—

(3010813) Leukocytes [#/volume] in Blood

13057

120180

14.49

225.46

44.2

19.7

7.2

6.8

e9/l

32.73

12847

116747

(3035941) MCH [Entitic mass]

13053

120122

13.90

225.12

43.9

19.5

30.2

5.95

13012

118440

(3026361) Erythrocytes [#/volume] in Blood

13054

120145

14.03

224.99

44.1

19.6

4.4

4.5

e12/l

141.35

12851

116745

(3024731) MCV [Entitic volume]

13052

120130

13.73

224.47

44.0

19.6

90.9

90.7

5.63

13010

118444

(3000963) Hemoglobin [Mass/volume] in Blood

13055

120184

14.14

224.46

44.5

19.7

130.1

135.3

g/l

274.25

13011

118493

(3028271) Lactate [Moles/volume] in Capillary blood

637

1606

4.12

224.19

2.6

1.8

1.6

1.7

mmol/l

2.31

622

1574

(3028026) IgM [Mass/volume] in Serum or Plasma

1463

6070

2.59

224.03

2.4

1.8

1.3

g/l

0.00

1358

5545

(3036489) Thrombin time

1079

3832

2.98

222.74

3.2

2.1

22.0

21.4

1.95

991

3302

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

964

3216

3.15

221.89

4.2

2.4

90.7

91.1

0.23

927

2989

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1169

4379

2.83

218.72

5.1

2.9

0.6

0.7

8.40

1148

4183

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

506

1095

4.76

216.54

2.1

1.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

3868

23790

1.89

216.50

2.2

1.9

—

(3044640) Blood type and Crossmatch panel - Blood

5058

33872

1.80

214.33

3.6

2.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

4454

28757

1.83

212.69

4.7

3.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

895

2930

3.20

212.44

3.5

2.5

207.7

185.1

9.90

866

2773

(3024928) Oxygen saturation in Venous blood

713

2032

3.65

210.63

5.6

3.4

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1946

9424

2.25

210.01

2.6

2.3

0.2

g/l

0.63

1811

8749

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1303

5275

2.63

209.18

3.8

2.7

0.3

e6/l

0.19

1283

5131

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

6875

50770

1.74

203.73

5.7

4.0

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

546

1337

4.22

199.60

2.0

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

523

1240

4.35

199.47

1.7

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

542

1323

4.23

198.96

1.9

1.4

—

(3026493) Urate [Moles/volume] in Serum or Plasma

4172

26907

1.81

196.54

4.0

2.6

2147.8

4385.0

umol/l

5.44

3726

23360

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2225

11732

2.08

191.75

4.0

2.7

7.4

8.3

umol/l

1.67

1910

10098

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

563

1463

3.97

189.75

1.8

1.4

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1135

4502

2.66

189.15

5.8

3.4

25.3

25.0

mmol/l

1.82

1097

4355

(3017143) Hepatitis C virus Ab [Presence] in Serum

2478

13655

2.00

188.75

2.0

1.6

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

8901

71479

1.76

188.13

4.1

3.0

53.7

45.6

u/l

9.10

8435

66771

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

359

651

5.64

187.82

2.0

1.6

—

(3026250) Tacrolimus [Mass/volume] in Blood

282

406

7.07

185.47

45.7

33.8

7.5

7.3

ug/l

0.74

268

375

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1730

8433

2.21

181.91

4.5

2.8

193.9

204.5

ng/l

0.53

1619

7630

(3047181) Lactate [Moles/volume] in Blood

884

3149

2.94

180.51

7.2

5.9

1.3

mmol/l

0.55

833

2764

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

10969

94414

1.98

178.44

6.9

5.4

40.4

39.4

mmol/mol

21.21

10270

87464

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

903

3279

2.88

177.98

2.9

2.6

—

(3022217) INR in Platelet poor plasma by Coagulation assay

2395

13302

1.98

177.19

24.8

25.6

1.4

inr

0.15

332

1906

(3004588) Protein electrophoresis panel - Serum or Plasma

1443

6651

2.31

173.17

2.9

2.2

—

(40761536) Microorganisms panel - Urine sediment

1849

9437

2.12

172.26

5.4

3.8

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

935

3521

2.78

171.98

2.9

2.2

788.1

618.2

ug/l

0.27

894

3285

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

689

2200

3.25

169.78

1.7

1.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

11456

100654

2.08

167.83

5.0

4.3

6.0

5.9

mmol/l

16.16

10682

91917

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1539

7381

2.23

167.63

6.3

3.8

120.5

90.3

ng/l

15.22

1342

6356

(3010421) pH of Blood

786

2753

2.97

165.15

5.6

3.8

7.4

0.36

696

2326

(3022313) Gas panel - Capillary blood

1129

4777

2.49

163.78

7.1

3.9

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

648

2039

3.29

163.47

1.9

1.5

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

676

2187

3.20

162.89

1.7

1.4

16.4

24.1

u/ml

0.89

(44790047)

445

1095

4.17

161.37

2.0

1.4

—

(44790048)

445

1095

4.17

161.37

2.0

1.4

—

(44790049)

445

1095

4.17

161.37

2.0

1.4

—

(44806118)

445

1095

4.17

161.37

2.0

1.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

817

2966

2.87

160.75

2.0

1.7

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

636

2000

3.29

160.56

1.8

1.4

114.2

110.2

u/ml

0.28

150

422

(3007164) IgA [Mass/volume] in Serum or Plasma

3329

21091

1.77

160.46

1.8

1.4

2.4

g/l

0.13

2258

12979

(3027315) Oxygen [Partial pressure] in Blood

708

2385

3.08

159.23

5.6

3.9

8.7

kpa

0.06

699

2334

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1705

8680

2.11

159.04

1.6

1.4

—

(3012501) Base excess in Blood by calculation

705

2372

3.08

158.88

5.6

3.9

2.4

2.5

mmol/l

0.24

488

1554

(3042733) HLA Ab [Presence] in Serum

220

285

7.83

158.82

5.4

4.6

—

(3013290) Carbon dioxide [Partial pressure] in Blood

705

2373

3.08

158.76

5.6

3.9

5.0

kpa

0.58

696

2323

(3004809) Band form neutrophils/100 leukocytes in Blood

552

1604

3.55

157.81

3.7

3.4

1.1

1.5

2.24

444

1227

(3029937) Albumin [Presence] in Urine by Test strip

4225

28796

1.69

155.50

5.6

3.9

0.0

estimate

0.10

1956

9836

(3034860) Kappa light chains.free [Mass/volume] in Serum

820

3036

2.81

155.41

3.9

3.1

58.9

74.6

mg/l

0.39

668

2452

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

819

3031

2.81

155.34

3.9

3.1

62.2

46.3

mg/l

1.01

668

2447

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

3141

19724

1.78

155.29

2.0

1.7

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

803

2953

2.83

154.11

3.8

3.0

2.5

3.1

ratio

0.25

257

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1009

4167

2.54

153.80

7.2

3.8

48.4

48.9

0.30

993

4115

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

662

2204

3.11

151.82

1.5

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

662

2204

3.11

151.82

1.5

1.3

—

(3013512) EKG study

4152

28313

1.68

151.68

5.3

3.8

—

(3019309) Folate [Moles/volume] in Red Blood Cells

3105

19552

1.77

151.49

1.9

1.8

1179.0

1169.4

nmol/l

0.21

2338

14829

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1622

8271

2.10

150.09

6.2

3.7

1.2

mmol/l

4.93

1470

7172

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

640

2108

3.14

149.45

1.5

1.3

253.4

261.6

u/ml

0.26

441

1317

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1035

4387

2.47

149.11

1.7

1.6

9.9

14.9

u/ml

0.71

132

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

5553

40879

1.62

149.09

5.4

3.7

—

(3000494) Fungus identified in Specimen by Culture

2110

11842

1.93

148.87

1.9

1.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

3725

24791

1.70

148.48

4.6

3.6

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

918

3692

2.60

147.68

2.7

2.2

7.6

7.4

g/l

2.60

678

2750

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

664

2251

3.05

147.53

1.4

1.2

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

917

3688

2.60

147.52

2.7

2.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

441

1151

3.93

147.45

7.8

12.5

7.6

7.3

mmol/l

0.43

391

938

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

916

3684

2.60

147.35

2.7

2.2

3.7

3.8

g/l

1.65

657

2624

(3048929) Epstein Barr virus Ab [Presence] in Serum

928

3763

2.58

146.76

1.4

1.3

—

(3018572) Chloride [Moles/volume] in Blood

657

2228

3.05

145.87

8.0

6.9

104.2

105.2

mmol/l

5.48

639

1973

(3039000) Anion gap in Blood

656

2228

3.05

145.25

8.0

6.8

11.2

11.3

mmol/l

0.30

638

1973

(3037522) Nuclear Ab [Titer] in Serum

2397

14230

1.84

141.22

1.5

1.3

427.2

536.2

titre

2.47

479

2845

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

866

3471

2.60

140.12

2.8

2.2

3.3

3.1

g/l

5.57

666

2692

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

451

1243

3.72

139.42

7.5

6.6

11.8

11.5

mg/l

0.74

418

1137

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

810

3149

2.67

139.36

3.0

2.2

1.1

0.9

g/l

0.53

686

2694

(3022806) Fractional oxyhemoglobin in Capillary blood

467

1324

3.62

138.44

2.3

1.8

90.5

89.7

1.97

462

1304

(3017569) Oxygen content in Arterial blood

248

424

5.94

137.95

2.0

2.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3799

25871

1.66

136.47

3.7

2.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

312

662

4.80

136.45

1.4

1.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

840

3446

2.54

129.27

2.8

2.2

10.3

g/l

0.09

703

2878

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

327

769

4.33

125.76

2.0

1.4

—

(3037756) Immunofixation for Serum or Plasma

579

1993

2.99

124.99

1.6

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

11611

104723

1.93

124.90

5.1

4.5

2.6

2.7

mmol/l

53.61

10782

96669

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

953

4207

2.36

124.80

7.5

4.1

24.9

24.7

mmol/l

1.56

890

3888

(3019977) pH of Arterial blood

267

536

5.06

124.63

3.0

2.5

7.4

0.65

115

176

(3009542) Hematocrit [Volume Fraction] of Blood

11178

99649

1.81

124.55

32.7

14.2

38.8

39.9

33.59

8062

73521

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

626

2257

2.86

124.23

1.7

1.6

—

(3023183) Ammonium ion [Moles/volume] in Plasma

597

2100

2.93

123.95

3.0

2.7

30.5

34.3

umol/l

3.78

516

1773

(3009508) Creatinine [Moles/volume] in Urine

4436

32019

1.58

122.51

3.9

3.2

7.1

7.7

mmol/l

15.59

3764

26889

(3023419) Bacteria identified in Sputum by Culture

410

1161

3.61

121.67

2.7

2.5

—

(3011648) Oxygen content in Venous blood

318

752

4.31

121.41

5.0

3.1

10.6

11.1

1.19

318

752

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

3735

26020

1.61

119.17

1.8

1.6

1.5

1.4

mmol/l

9.13

3239

21950

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

707

2779

2.63

118.63

2.8

2.1

0.0

g/l

0.22

654

2533

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

722

2872

2.60

118.24

6.7

3.9

1.8

1.5

mg/l

15.00

675

2634

(40768446) Kidney Pathology biopsy report

215

372

5.86

118.12

2.1

1.6

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

702

2763

2.63

117.46

1.7

1.4

16.9

11.2

iu/ml

0.51

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

340

868

3.99

117.13

3.8

3.6

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

365

984

3.79

116.43

3.5

3.4

63.3

57.6

4.13

257

617

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

3259

22070

1.63

116.24

1.8

1.7

8621770.4

29433651.7

pmol/l

3.03

2691

18367

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

715

2874

2.57

114.55

2.8

2.0

35.7

37.8

g/l

13.57

610

2460

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

11409

102907

1.82

114.50

4.7

4.1

4.4

4.6

mmol/l

65.32

10616

95570

(3020682) Albumin/Creatinine [Ratio] in Urine

4181

30194

1.56

113.03

4.9

4.0

19.3

10.0

mg/mmol

11.39

2857

19372

(3024932) HLA-DR beta [Type]

186

292

6.45

112.70

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

397

1158

3.50

112.59

1.2

1.3

—

(21494815) CD4 cells/100 lymphocytes in Specimen

334

867

3.93

112.42

2.2

2.4

39.5

43.2

0.53

108

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

413

1239

3.41

112.11

2.4

2.5

—

(3024471) HLA-A [Type]

187

298

6.35

111.66

1.0

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

211

381

5.61

110.82

1.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

11309

102116

1.77

108.01

4.6

4.1

1.4

mmol/l

54.46

10467

94390

(3008757) Leukocyte morphology finding [Identifier] in Blood

372

1069

3.55

107.93

4.0

3.9

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

282

670

4.28

107.00

1.2

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

212

405

5.30

104.69

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

259

593

4.43

103.08

1.9

1.4

—

(3010375) cycloSPORINE [Mass/volume] in Blood

216

426

5.14

102.91

36.2

24.1

123.8

117.0

ug/l

0.63

176

354

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

785

3462

2.35

102.55

1.9

1.6

253.5

318.5

titre

0.33

155

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

639

2577

2.55

101.49

2.9

2.1

0.0

g/l

1.01

588

2338

(3012516) Albumin [Mass/volume] in Urine

3966

28868

1.53

100.85

3.9

3.3

513.5

404.3

mg/l

0.74

2711

18639

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

630

2534

2.56

100.60

2.9

2.1

0.0

g/l

0.00

587

2328

(3018405) Lactate [Moles/volume] in Arterial blood

791

3548

2.31

99.29

4.4

4.0

1.3

1.4

mmol/l

1.57

767

3492

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

10953

98568

1.67

99.28

4.3

3.7

1.3

mmol/l

19.35

10177

90555

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

506

1854

2.80

97.19

1.8

1.6

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

456

1582

2.95

96.87

1.9

1.5

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

196

376

5.28

96.35

3.1

2.4

—

(4035726)

1503

8620

1.84

95.95

1.6

1.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

221

473

4.73

95.65

1.9

2.1

—

(40768797) Stomach Pathology biopsy report

2160

13781

1.68

94.79

1.3

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1506

8695

1.83

93.96

2.6

2.3

8.3

7.0

ug/l

1.20

1265

7512

(40760888) Immunoglobulin light chains.free panel - Serum

577

2301

2.58

93.71

3.8

3.2

—

(3003694) ABO and Rh group [Type] in Blood

4247

31798

1.50

92.58

1.7

1.5

—

(3003181) Sodium [Moles/volume] in Urine

461

1679

2.81

89.51

1.5

1.4

61.8

63.5

mmol/l

0.35

375

1339

(3005322) IgE [Units/volume] in Serum or Plasma

1219

6683

1.91

89.32

1.4

1.3

211.5

246.3

u/ml

0.61

1130

6159

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

340

1056

3.28

87.25

2.0

1.6

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

318

955

3.39

86.14

2.0

1.7

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

225

533

4.28

85.72

2.0

1.4

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

689

3105

2.29

85.30

1.9

1.7

0.2

g/l

1.52

662

2940

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

252

652

3.92

85.21

1.3

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

225

539

4.23

84.47

2.0

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

254

665

3.87

84.47

1.3

1.4

—

(3011412) CD3 cells [#/volume] in Blood

326

1009

3.29

84.13

2.3

2.5

1.2

e9/l

0.07

200

613

(3045142) Bone marrow Pathology biopsy report

330

1041

3.23

82.55

1.5

1.3

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

699

3212

2.24

82.55

1.9

1.7

1.2

g/l

0.64

673

3049

(3045414) Leukocytes [Presence] in Urine

917

4687

2.03

82.14

2.6

1.8

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

196

435

4.56

81.16

1.8

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

196

435

4.56

81.16

1.8

1.5

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

580

2482

2.40

80.83

1.4

1.2

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

116

158

7.40

80.20

6.1

5.2

—

(3002256) Pathology report gross observation

2067

13582

1.62

79.35

1.3

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

273

809

3.42

75.53

2.1

2.2

11.0

13.8

3.00

124

415

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

535

2276

2.41

75.50

1.5

1.3

—

(3025941) Bacteria identified in Stool by Culture

1102

6173

1.86

74.98

1.3

1.2

—

(3036782) Glucose [Moles/volume] in Pleural fluid

283

873

3.29

73.44

1.4

6.4

6.3

mmol/l

0.36

273

790

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3294

24319

1.47

73.41

1.4

1.3

1.2

1.7

u/ml

2.36

968

6605

(3003434) Protein [Mass/volume] in Pleural fluid

360

1284

2.85

72.65

1.5

32.2

32.3

g/l

0.03

325

1149

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

528

2274

2.38

72.47

1.7

1.5

2151.7

2613.6

e6/l

0.09

413

1853

(3024980) IgG subclass 4 [Mass/volume] in Serum

430

1685

2.60

72.27

1.8

1.6

0.7

0.8

g/l

1.38

314

1259

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

527

2272

2.37

72.16

1.7

1.5

15.5

24.7

e6/l

0.59

385

1753

(40768804) Tissue Pathology biopsy report

5247

42402

1.39

70.04

2.3

2.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

149

300

5.01

69.39

1.8

1.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

683

3335

2.10

68.99

1.7

1.6

8.8

7.7

iu/ml

0.04

139

732

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

814

4238

1.98

68.92

1.9

36.3

39.1

u/l

3.82

723

3763

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

452

1856

2.49

68.88

5.5

3.1

—

(3020891) Body temperature

790

4086

1.99

68.15

6.7

4.7

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

251

761

3.34

67.00

2.1

2.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

994

5578

1.85

66.98

2.8

2.3

4875.1

6389.9

u/l

0.94

454

2201

(3048689) Calprotectin [Mass/mass] in Stool

1995

13494

1.56

66.60

2.7

2.4

152.7

129.8

ug/g

2.01

1581

10559

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

496

2159

2.35

66.41

1.9

1.7

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2955

21711

1.47

66.38

1.8

1.6

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

388

1511

2.61

66.03

5.9

4.9

382.4

360.6

umol/l

2.16

340

1286

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

270

864

3.17

65.98

1.3

472.9

388.5

u/l

0.37

262

812

(3000492) Spirometry study

1567

10030

1.64

65.90

1.7

1.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

383

1486

2.62

65.67

1.1

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

260

823

3.20

64.70

1.9

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

260

823

3.20

64.70

1.9

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

260

823

3.20

64.70

1.9

1.7

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

413

1689

2.49

63.48

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

722

3708

2.00

63.46

1.5

1.3

—

(3045424) Erythrocytes [Presence] in Urine

420

1734

2.47

63.25

1.7

1.5

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

555

2589

2.19

62.96

1.6

1.4

608.8

503.9

mg/l

1.11

530

2458

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

237

726

3.31

62.24

2.1

1.8

4.3

4.1

mg/l

0.42

226

689

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

140

295

4.79

61.83

3.8

2.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

140

295

4.79

61.83

3.8

2.4

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

559

2659

2.15

60.35

2.0

11.9

10.9

mg/l

0.92

519

2489

(3044290) Cell count panel - Cerebral spinal fluid

474

2112

2.29

60.08

1.7

1.5

—

(3010503) CD19 cells [#/volume] in Blood

204

582

3.54

59.90

2.4

2.7

1.0

0.4

e9/l

0.72

198

568

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

386

1580

2.49

59.21

1.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2447

17697

1.47

58.59

1.3

34.3

31.9

iu/ml

0.29

763

5396

(3027456) Digoxin [Moles/volume] in Serum or Plasma

438

1910

2.34

58.38

3.3

3.1

0.8

nmol/l

0.04

346

1458

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

223

688

3.28

57.91

22.7

18.3

4842.5

2749.2

nmol/l

0.26

213

667

(3023199) Leukocytes [#/volume] in Pleural fluid

307

1136

2.74

57.81

1.5

2557.0

2479.2

e6/l

0.05

191

825

(3024891) Influenza virus A+B Ag [Presence] in Specimen

586

2902

2.07

56.88

1.3

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

302

1119

2.74

56.73

1.3

1.2

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

12.55

56.27

1.3

1.1

—

(3042631) Mycobacterium sp identified in Specimen

336

1319

2.59

56.26

2.9

2.7

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

488

2274

2.19

55.47

1.6

1.4

3.8

3.7

mmol/l

0.94

464

2126

(4062490)

290

1068

2.75

55.12

1.5

1.3

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

217

679

3.23

55.09

1.3

16.2

13.3

u/l

0.36

204

619

(3043409) Potassium [Moles/volume] in Arterial blood

601

3051

2.02

54.47

5.2

4.3

3.8

3.9

mmol/l

1.48

517

2865

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

176

486

3.66

54.30

1.3

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

176

486

3.66

54.30

1.3

1.4

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

196

581

3.41

54.28

2.4

95.7

95.8

0.01

188

536

(3022145) Colonoscopy Study observation

1680

11416

1.54

53.98

1.4

1.3

—

(21494814) CD8 cells/100 lymphocytes in Specimen

151

380

4.01

53.17

2.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

379

1622

2.38

52.72

1.4

1.2

2.2

3.4

u/ml

1.68

149

544

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2287

16639

1.45

52.38

1.3

12.4

11.4

u/ml

0.26

840

6495

(3052851) Hemolysis interference index of Serum or Plasma

609

3151

1.98

52.27

3.7

3.2

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

9.57

52.06

3.3

3.7

2.1

2.3

mg/l

0.18

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

225

748

3.04

51.58

2.2

2.7

587.4

513.7

e6/l

1.09

183

625

(3027135) IgG subclass 1 [Mass/volume] in Serum

284

1071

2.69

51.57

1.6

1.3

6.2

6.8

g/l

1.49

191

726

(3024139) IgG subclass 3 [Mass/volume] in Serum

284

1071

2.69

51.57

1.5

1.3

0.4

g/l

0.43

190

727

(3028192) IgG subclass 2 [Mass/volume] in Serum

284

1072

2.69

51.47

1.6

1.3

2.5

3.0

g/l

3.93

192

728

(3045788) Cell count panel - Pleural fluid

247

870

2.87

51.07

1.6

1.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

117

252

4.67

50.38

1.4

1.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1068

6624

1.67

50.15

3.3

4.4

4.5

pmol/l

4.76

987

5872

(3012441) Differential panel - Pleural fluid

268

996

2.73

50.08

1.5

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

4159

33685

1.34

49.68

4.8

5.0

3.1

3.3

ug/l

0.20

3757

30153

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

221

745

3.00

49.46

2.3

2.8

666.1

705.6

e6/l

0.33

290

(3028308) Erythrocytes [#/volume] in Pleural fluid

273

1031

2.68

49.44

1.5

51943.6

63618.9

e6/l

0.22

128

619

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

111

6.88

49.41

2.7

1.6

—

(3017732) Neutrophils [#/volume] in Blood

1164

7415

1.62

49.13

3.7

2.7

4.3

4.2

e9/l

0.72

834

5806

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

139

352

3.98

48.56

2.1

1.7

2379.9

49138.2

u/ml

0.84

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

216

731

2.99

48.02

2.3

2.7

0.2

e9/l

3.06

181

623

(4268621)

280

1090

2.60

47.73

2.5

2.3

—

(3004451) EKG impression Narrative

164

473

3.50

47.44

1.5

1.3

—

(1761868) Lipid panel - Serum or Plasma

4494

37002

1.33

47.35

3.0

2.6

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

359

1574

2.32

47.26

1.4

1.2

3.8

3.9

u/ml

0.03

183

698

(21494890) Protein electrophoresis panel - 24 hour Urine

258

973

2.68

46.87

2.1

2.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

254

951

2.70

46.80

1.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

295

1189

2.51

46.80

1.2

1.1

—

(4010399)

1106

7099

1.61

45.11

1.6

1.4

—

(3023410) Appearance of Cerebral spinal fluid

263

1021

2.61

45.10

1.9

1.8

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

341

1494

2.32

44.97

1.2

1.1

119.5

115.6

1.15

317

1337

(40768806) Pleura Pathology biopsy report

260

1007

2.61

44.80

1.5

1.6

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1931

13977

1.45

44.72

1.8

1.7

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

154

444

3.50

44.59

1.4

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1464

10045

1.51

44.38

4.2

4.0

8.5

28.1

ug/l

4.53

1202

8099

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

414

1977

2.13

44.21

1.5

1.2

52.7

196.4

titre

1.43

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

374

1718

2.21

44.05

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

551

2923

1.92

43.90

1.4

269.6

272.9

ug/g

0.14

309

1694

(3016018) Differential panel - Cerebral spinal fluid

274

1107

2.51

43.27

1.8

1.5

—

(3025315) Body weight

7.79

42.86

4.8

4.5

—

(3000330) Specific gravity of Urine by Test strip

793

4738

1.72

42.65

5.0

3.2

—

(3008037) Lactate [Moles/volume] in Venous blood

396

1891

2.13

42.29

6.5

3.1

1.5

1.6

mmol/l

4.59

389

1840

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

147

426

3.48

42.25

4.3

3.4

—

(3019150) Specific gravity of Urine by Refractometry

2981

23488

1.35

41.23

5.4

3.9

1.0

kg/l

0.11

345

3587

(3000093) Morphology [Interpretation] in Blood Narrative

249

984

2.56

41.20

1.2

1.1

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

344

1576

2.21

40.80

2.5

1.9

11.3

8.0

titre

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

154

472

3.29

40.54

1.1

4.7

3.6

iu/ml

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

263

1084

2.45

39.82

1.2

1.1

94.7

95.2

0.10

248

1012

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

352

1644

2.17

39.80

1.7

1.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

132

375

3.54

39.14

3.1

2.4

—

(4306422)

337

1564

2.18

38.72

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

172

579

3.00

38.68

2.4

2.8

39.8

39.5

0.04

203

(3049717) Cytology report of Urine Cyto stain

654

3816

1.75

38.23

2.6

2.7

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

565

3169

1.82

37.77

2.1

1.8

—

(3035880) pH of Pleural fluid

157

509

3.11

37.69

1.3

—

(3021788) Differential panel - Synovial fluid

369

1797

2.08

37.45

1.7

1.5

—

(4198724)

169

576

2.96

37.19

2.5

2.7

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

334

1575

2.15

36.87

1.2

1.1

—

(21494434) Karyotype in Bone marrow

213

824

2.61

36.86

1.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

517

2846

1.85

36.72

1.4

1.3

109.2

134.5

titre

0.42

262

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

688

4121

1.71

36.59

1.9

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

112

299

3.77

36.43

2.1

2.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

642

3787

1.73

36.09

1.3

225.2

229.3

miu/ml

0.10

258

1778

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

144

458

3.17

35.73

2.0

2.2

98.2

149.7

umol/l

1.72

237

(3034770) Mitochondria Ab [Titer] in Serum

505

2809

1.83

34.68

1.3

450.0

1004.5

titre

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

192

4.45

34.62

3.1

2.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

186

696

2.70

34.42

1.3

1.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

313

1485

2.13

34.04

1.4

1.3

—

(3045716) Anion gap in Serum or Plasma

138

441

3.15

33.99

2.1

2.2

8.4

9.2

mmol/l

1.88

100

343

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

293

1356

2.19

33.94

1.6

1.4

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

161

563

2.88

33.87

1.4

1.2

112.3

85.7

u/l

2.05

150

484

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

208

830

2.53

33.81

1.4

1.2

85.3

210.2

titre

4.27

159

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

585

3426

1.74

33.73

3.5

3.4

400.9

2194.4

u/ml

1.36

489

2931

(3035637) Corticotropin [Mass/volume] in Plasma

288

1328

2.19

33.67

1.6

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

157

545

2.90

33.48

1.4

1.2

31.7

21.5

u/l

1.83

146

461

(3014051) Protein [Presence] in Urine by Test strip

442

2385

1.88

33.43

3.4

2.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

516

2922

1.80

33.41

1.4

1.3

—

(3038515) Glucose [Moles/volume] in Venous blood

353

1765

2.03

33.38

7.0

3.2

7.5

7.6

mmol/l

0.46

348

1721

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

206

830

2.50

32.82

1.4

1.2

76.3

150.0

titre

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

286

1329

2.18

32.81

1.6

1.4

—

(3047189) Immunofixation for 24 hour Urine

136

441

3.10

32.70

1.7

1.6

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

231

983

2.37

32.67

3.6

2.9

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

285

1325

2.18

32.65

1.6

1.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

563

3308

1.73

32.08

1.9

1.8

—

(3036603) Volume of Urine

168

625

2.71

31.49

1.9

1.6

1793.1

1938.9

0.33

140

(3025468) Yersinia sp identified in Specimen by Organism specific culture

281

1320

2.15

31.38

1.6

1.4

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

145

502

2.91

31.10

2.2

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

145

502

2.91

31.10

2.2

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

145

502

2.91

31.10

2.2

1.9

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

281

1326

2.14

31.02

1.6

1.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

605

3659

1.68

31.00

1.8

1.7

—

(3037121) Protein [Mass/volume] in Urine

603

3653

1.68

30.71

4.2

3.2

0.6

0.3

g/l

2.07

345

1609

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

280

1325

2.14

30.69

1.6

1.4

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

689

4326

1.63

30.50

1.1

80.6

2.4

u/ml

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

466

2632

1.80

30.44

1.6

1.4

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

144

503

2.88

30.40

2.2

1.9

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

10.67

30.40

1.3

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

416

2274

1.86

30.23

3.0

2.9

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

209

889

2.37

29.63

1.6

1.4

1.3

promille

0.22

163

680

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

3250

26901

1.28

29.56

4.2

4.3

22.5

22.0

1.02

1500

13067

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

107

320

3.36

29.42

1.2

1.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1163

8246

1.45

29.30

3.8

2.6

58.7

67.4

ml/min/173m2

9.16

546

3252

(3000475) Leukocytes [#/volume] in Synovial fluid

423

2354

1.82

29.03

1.9

1.6

18065.1

13228.4

e6/l

0.64

284

1702

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

226

1006

2.27

28.85

1.3

1.2

74.6

65.9

u/l

0.29

188

661

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

473

2740

1.75

28.35

1.2

1.1

—

(3044941) Cell count panel - Synovial fluid

302

1516

2.01

28.29

1.5

1.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1784

13687

1.35

28.14

1.9

1.7

1.6

1.4

7.94

1556

12072

(1761482) Bacteria [#/volume] in Urine by Culture

400

2214

1.83

27.95

5.5

4.0

—

(3008295) Osmolality of Serum or Plasma

226

1020

2.24

27.92

1.4

1.5

279.6

280.3

mosm/kgh2o

0.15

168

781

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

2058

16150

1.32

27.81

2.4

2.2

—

(3012565) Volume of 24 hour Urine

139

502

2.79

27.63

2.7

2.2

1874.9

1963.0

0.40

125

441

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

7.77

27.60

9.3

10.4

527.7

183.9

e6/l

0.52

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

6.58

27.58

2.8

3.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

194

827

2.37

27.40

1.4

1.2

2.2

2.0

mmol/l

0.64

180

777

(3022493) Free Hemoglobin [Mass/volume] in Plasma

127

439

2.91

27.38

10.6

4.6

1486.3

603.5

mg/l

0.25

103

311

(3018851) Theophylline [Moles/volume] in Serum or Plasma

6.15

27.00

1.7

43.5

44.3

umol/l

0.06

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

144

538

2.69

26.84

1.5

1.3

59.7

66.1

0.35

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

786

5245

1.53

26.69

2.5

2.4

—

(40757373) Influenza virus identified in Isolate

194

3.93

26.44

2.0

1.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

176

732

2.42

26.28

1.4

1.3

1.8

1.5

u/ml

0.11

301

(40768795) Lymph node Pathology biopsy report

210

946

2.24

26.09

1.4

1.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

245

1182

2.09

25.61

1.8

1.5

61.2

58.3

0.53

154

764

(3020876) Protein [Mass/time] in 24 hour Urine

195

861

2.28

25.43

2.2

1.9

1.5

1.2

g/24h

—

(3000034) Microalbumin [Mass/volume] in Urine

204

919

2.24

25.36

3.7

3.0

145.0

61.7

mg/l

1.44

157

683

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

255

1254

2.05

25.33

1.2

1.1

1.6

2.4

iu/ml

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

144

557

2.60

25.08

1.2

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

204

927

2.22

24.84

1.5

1.4

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

432

2535

1.73

24.76

1.3

9.9

5.6

u/ml

0.27

263

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

114

393

2.92

24.74

2.4

2.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

300

3.22

24.66

2.6

3.3

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

466

2798

1.69

24.56

1.3

34.1

40.0

u/ml

0.20

174

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

113

391

2.91

24.37

2.3

2.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

113

391

2.91

24.37

2.3

2.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

5.56

24.36

1.3

1.2

—

(3016038) Potassium [Moles/volume] in Urine

159

654

2.45

24.36

1.2

33.0

34.4

mmol/l

0.32

142

560

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

174

746

2.35

24.31

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

174

746

2.35

24.31

1.2

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

234

3.52

24.31

1.5

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

138

531

2.62

24.31

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

175

753

2.34

24.25

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

174

747

2.35

24.24

1.2

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

631

4097

1.57

24.23

1.3

1.2

0.9

1.0

u/ml

0.07

368

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

7.87

24.23

4.8

5.6

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

434

2573

1.71

23.98

1.3

11.1

9.0

u/ml

0.21

418

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

174

753

2.33

23.81

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

174

753

2.33

23.81

1.2

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

103

343

3.02

23.78

2.2

2.4

374.4

588.2

e6/l

0.39

190

(3021387) Prolactin [Units/volume] in Serum or Plasma

693

4617

1.53

23.69

1.7

1.6

339.1

302.6

mu/l

1.68

601

4154

(3022689) Creatine [Moles/volume] in Urine

278

3.25

23.58

1.9

1.4

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

193

877

2.22

23.53

1.8

1.5

31.0

30.1

0.12

117

551

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1853

14642

1.31

23.47

2.3

2.1

—

(3051611) Lipemic interference index of Serum or Plasma

223

1080

2.08

23.12

4.2

3.3

—

(3000012) Reticulocyte production index

143

574

2.51

23.11

1.8

1.4

—

(36660697) Celiac disease serology panel - Serum

1171

8656

1.39

23.11

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

126

476

2.66

23.05

4.1

3.9

—

(3008536) Aspergillus sp Ab [Presence] in Serum

182

3.81

22.98

1.6

2.2

—

(3017704) Immunofixation for Urine

132

513

2.59

22.82

1.6

1.5

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

303

1647

1.86

22.50

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

163

3.94

22.39

1.6

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1033

7529

1.40

22.13

1.3

1.2

139.1

141.2

iu/ml

0.04

386

2816

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

2348

19256

1.27

22.08

2.9

3.0

0.8

ug/l

0.19

1604

12832

(3006922) Hepatitis E virus Ab [Presence] in Serum

167

736

2.28

21.94

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

245

1253

1.97

21.87

1.3

93.2

53.3

u/ml

0.68

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

364

2109

1.75

21.86

1.3

52.8

43.2

u/ml

0.44

203

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

359

2074

1.75

21.79

1.3

1.2

8.2

6.3

u/ml

0.12

154

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

128

502

2.56

21.74

1.5

1.7

166.8

139.1

3.06

118

470

(3022621) pH of Urine by Test strip

960

6936

1.41

21.62

3.5

2.9

—

(3020961) Endomysium IgA Ab [Titer] in Serum

769

5334

1.47

21.59

1.1

113.0

239.3

titre

1.31

149

(3003338) MCHC [Mass/volume]

9798

92666

1.22

21.44

38.8

17.0

330.9

332.7

g/l

67.29

9769

91893

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

155

3.95

21.42

2.4

2.8

57.4

62.0

mg/l

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

381

2251

1.71

21.35

4.5

3.5

25.9

27.9

mg/l

0.52

278

1396

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

328

1858

1.78

21.31

4.4

2.0

0.9

0.8

nmol/l

1.41

281

1567

(3014765) Yersinia sp identified in Stool by Organism specific culture

491

3103

1.60

21.17

1.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

263

1397

1.90

21.01

1.1

1.5

g/l

0.12

239

1266

(42529406) Shigella sp [Presence] in Stool by Culture

492

3118

1.60

20.97

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

486

3077

1.60

20.80

1.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

450

2808

1.62

20.45

1.4

1.5

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

293

3.02

20.39

1.4

1.5

2.3

2.7

0.16

246

(3000919) Neutrophils/100 leukocytes in Pleural fluid

262

3.14

20.38

1.4

1.5

22.9

20.8

0.26

239

(3009871) Measles virus Ab [Titer] in Serum

348

2.83

20.24

1.5

1.7

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

354

2.81

20.18

1.4

1.5

63.2

65.1

0.20

289

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

153

674

2.28

20.17

1.1

—

(3014271) Vancomycin [Susceptibility]

128

522

2.47

20.07

3.1

2.9

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

362

2146

1.71

20.06

1.4

—

(3043410) Blood group antigens tested for on Red Blood Cells

275

3.07

20.05

2.2

1.7

—

(3044927) Protein electrophoresis panel - Urine

198

971

2.05

19.92

1.2

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

7.26

19.89

3.2

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

4.70

19.79

3.8

2.9

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

153

680

2.26

19.76

1.1

1.0

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

777

5494

1.44

19.71

1.4

22.6

24.9

iu/l

1.23

641

4713

(3001964) Herpes simplex virus Ag [Presence] in Specimen

294

2.97

19.66

2.1

1.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

400

2450

1.65

19.59

2.7

2.3

169.7

118.1

ug/min

0.93

252

1482

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

180

858

2.11

19.54

2.1

1.8

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

7.08

19.46

3.2

3.3

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

160

730

2.21

19.40

1.8

1.6

24.3

u/ml

0.00

153

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

140

3.94

19.30

5.0

5.3

75.3

39.5

ug/min

2.10

101

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

208

1056

1.98

19.03

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

292

1655

1.78

18.98

1.2

1.1

9.3

12.3

au/ml

0.39

(3023420) DNA double strand Ab [Units/volume] in Serum

217

1124

1.95

18.74

1.6

1.5

31.2

28.1

iu/ml

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

125

525

2.39

18.42

1.4

1.5

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

117

478

2.46

18.31

2.5

2.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

574

3885

1.50

18.22

1.6

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

602

4116

1.48

18.18

2.6

2.2

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

183

903

2.04

18.15

1.3

1.5

1.4

nmol/l

0.40

167

808

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

542

3628

1.51

18.15

1.7

1.5

—

(3011288) Drugs identified in Urine by Screen method

535

3583

1.51

17.87

3.7

3.0

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

351

2.69

17.70

1.3

1.1

97.7

108.3

1.75

315

(3046861) Legionella sp Ag [Presence] in Urine

6.31

17.52

1.3

1.0

—

(3011985) Renin [Units/volume] in Plasma

244

1344

1.83

17.47

1.5

56.5

66.4

mu/l

0.43

217

1191

(3016750) Collection duration of Urine

133

588

2.27

17.45

2.4

2.1

497.5

499.8

min

0.09

436

(3016879) Cocaine [Presence] in Urine

696

4934

1.43

17.40

2.6

2.2

—

(40757494) Bilirubin.total [Moles/volume] in Blood

129

566

2.29

17.24

3.1

2.4

30.8

51.0

umol/l

0.80

(3004775) Volume in Urine collected for unspecified duration

162

780

2.09

17.19

2.4

2.2

707.1

649.7

0.63

113

526

(3009214) Lutropin [Units/volume] in Serum or Plasma

539

3653

1.50

17.01

1.4

10.1

9.2

u/l

0.78

430

2988

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

248

1386

1.80

16.95

1.2

1.3

0.6

0.9

nmol/l

0.51

242

1332

(3034274) Bile acid [Moles/volume] in Serum --fasting

304

1802

1.70

16.92

2.5

2.2

5.7

6.9

umol/l

0.79

219

1337

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1067

8154

1.34

16.86

2.4

2.1

11.1

12.0

nmol/l

2.07

926

7195

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

278

1612

1.74

16.75

1.3

54.9

37.0

u/l

0.98

256

1389

(3029075) Extractable nuclear Ab panel - Serum

294

2.80

16.71

1.0

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

5.78

16.61

4.0

3.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

340

2.66

16.60

1.2

92.4

87.7

0.52

150

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

248

1397

1.79

16.52

1.2

1.3

0.4

0.2

nmol/l

0.34

(3012898) Urea [Moles/volume] in Urine

107

4.12

16.46

1.1

1.6

153.0

179.4

mmol/l

0.63

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

349

2.62

16.30

1.1

91.0

90.1

0.09

151

(40768443) Skin Pathology biopsy report

651

4624

1.43

16.11

1.2

—

(21491868) Cryoglobulin [Mass/volume] in Serum

352

2.60

16.02

1.1

1.2

0.7

0.3

g/l

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

137

640

2.15

15.76

1.3

434.0

306.7

titre

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

935

7078

1.35

15.73

2.3

20.9

23.2

au/ml

0.22

413

(3013139) Helicobacter pylori Ag [Presence] in Stool

898

6766

1.35

15.59

1.2

—

(3034426) Prothrombin time (PT)

363

2.54

15.57

1.3

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

729

5323

1.39

15.40

2.6

2.1

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

383

2.49

15.38

1.6

1.7

204.2

164.0

2.65

355

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

402

2.45

15.29

1.2

1.1

—

(3027008) Opiates [Presence] in Urine

732

5356

1.39

15.28

2.6

2.0

—

(3028433) Virus identified in Specimen by Culture

355

2.55

15.25

1.3

1.2

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

9.48

15.20

4.4

3.5

—

(3028300) Cannabinoids [Presence] in Urine

733

5370

1.39

15.18

2.6

2.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

132

620

2.14

15.00

1.3

40.0

69.5

titre

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

263

2.78

14.80

1.2

1.1

—

(3027944) Amphetamines [Presence] in Urine

719

5274

1.38

14.78

2.6

2.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

264

1571

1.69

14.55

1.3

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

4.18

14.54

1.6

1.5

1.8

2.0

mg/l

0.08

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

154

776

2.00

14.51

1.4

1.2

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

120

551

2.19

14.46

1.9

1.6

19.4

23.5

umol/l

0.91

108

525

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

222

1261

1.77

14.44

1.3

1.4

320.7

332.1

pmol/l

0.11

161

963

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

4.14

14.34

1.3

1.1

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

4.21

14.29

1.5

1.2

1.5

mg/l

0.18

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

4.21

14.29

1.5

mg/l

0.01

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

4.21

14.29

1.5

0.8

1.9

mg/l

1.67

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

4.21

14.29

1.5

1.7

1.5

mg/l

0.09

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

4.21

14.29

1.5

3.8

4.3

mg/l

0.16

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

4.21

14.29

1.5

2.9

3.3

mg/l

0.13

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

4.21

14.29

1.5

1.0

2.5

mg/l

1.76

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

4.21

14.29

1.5

1.7

2.6

mg/l

0.48

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

4.21

14.29

1.5

1.0

1.1

mg/l

0.10

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

4.03

14.20

2.3

2.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

192

1051

1.84

14.12

3.4

2.3

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

172

911

1.90

14.03

1.5

1.3

—

titre

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

7.92

14.00

4.7

4.8

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

147

739

2.00

13.96

1.8

1.6

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

194

1072

1.82

13.85

1.4

11.8

11.7

mmol/l

0.04

243

(3008116) Ketones [Moles/volume] in Urine by Test strip

202

2.98

13.78

1.7

1.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

212

3597

0.58

13.68

1.4

1.5

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

8.19

13.61

9.8

7.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

264

2.70

13.59

1.3

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

428

2902

1.49

13.54

1.5

1.4

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

103

457

2.26

13.52

1.6

1.5

5.7

3.4

0.73

114

(3028679) Herpes simplex virus Ab [Presence] in Serum

124

593

2.10

13.50

1.3

1.2

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

237

2.79

13.50

1.2

106.9

105.6

0.10

221

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

168

3.16

13.49

1.2

1.3

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

134

3.44

13.39

1.8

1.6

97.7

105.8

ug/l

0.24

112

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

217

1255

1.74

13.30

1.2

1.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

183

1011

1.82

13.11

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

141

715

1.98

13.10

1.2

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

208

2.89

13.10

1.1

—

(21494755) Public health laboratory ask at order entry panel

867

11134

0.76

12.92

1.3

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

164

880

1.87

12.89

1.1

—

(4027681)

134

677

1.99

12.60

1.4

1.3

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

145

754

1.93

12.55

1.5

1.4

13.4

12.2

umol/l

1.43

137

715

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

116

558

2.09

12.48

1.2

—

(3013862) HLA-DP [Type]

6.18

12.45

1.0

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

146

3.23

12.39

1.4

1.5

15.1

9.7

0.66

(1002224) Polysomnography panel

578

4214

1.39

12.36

1.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

6.46

12.35

1.5

1.1

—

(4015189)

245

2.66

12.16

2.9

2.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

164

899

1.83

12.08

1.6

1.3

94544.6

139110.2

e6/l

0.48

116

614

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

222

1328

1.68

12.08

2.1

1.7

2280.0

2137.8

titre

0.05

(3004716) Salmonella sp identified in Stool by Organism specific culture

761

5813

1.33

12.05

1.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

380

2578

1.49

12.04

1.8

1.9

4.2

4.3

iu/l

0.08

136

963

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

102

476

2.15

11.89

1.1

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

203

2.82

11.89

1.6

1.3

51.8

26.8

g/l

0.50

153

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

255

1588

1.62

11.86

1.2

1.1

61.2

6703.7

iu/ml

0.65

408

(40760409) HLA-A [Type] by High resolution

6.07

11.64

1.0

—

(40763590) HLA-DQ beta [Type]

6.07

11.64

1.0

—

(40760410) HLA-B [Type] by High resolution

6.07

11.64

1.0

—

(46236302) HLA-C [Type] by High resolution typing

6.07

11.64

1.0

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

132

3.26

11.58

1.3

1.2

1.6

1.8

mmol/l

0.09

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

832

6473

1.30

11.55

1.3

41.6

49.6

au/ml

0.43

259

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

118

589

2.01

11.52

1.1

1.0

u/l

0.38

252

(40768441) Liver Pathology biopsy report

139

737

1.90

11.40

1.9

1.4

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

115

3.40

11.19

1.3

25.6

330.5

u/l

0.60

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

353

2.30

11.17

3.4

2.9

29.6

28.4

umol/l

0.50

264

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

341

2.32

11.14

1.6

1.2

18.6

20.2

0.07

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

366

2.28

11.14

1.1

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

119

604

1.98

11.11

1.9

1.5

5.7

5.5

u/l

0.06

273

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

228

2.64

11.08

1.1

87.3

77.8

0.88

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

155

860

1.81

11.03

1.1

347.8

256.3

mg/l

0.87

129

753

(3047007) Chlamydophila sp Ab [Presence] in Serum

238

1487

1.61

10.96

1.2

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

459

2.12

10.95

2.7

2.4

60.0

52.3

umol/l

1.23

393

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

4.81

10.93

10.1

6.8

—

(3048879) Bone marrow aspiration report

271

2.48

10.90

1.6

1.8

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

230

2.62

10.90

1.2

1.1

75.1

71.3

0.25

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

122

3.28

10.90

1.2

—

(40762365) Oxygen content in Arterial blood by calculation

180

2.84

10.85

1.9

2.8

15.4

14.6

ml/dl

0.92

169

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

139

3.10

10.67

1.1

1.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

120

3.26

10.49

2.3

1.9

—

(3024263) Appearance of Synovial fluid

104

514

2.03

10.48

2.8

1.7

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

236

1489

1.60

10.46

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

158

898

1.77

10.40

1.2

55.9

40.8

mg/l

0.50

120

743

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

152

2.97

10.37

1.9

1.5

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

227

1423

1.61

10.34

3.2

2.7

99.1

538.8

u/ml

1.12

221

1337

(3041918) Cholesterol [Moles/volume] in Pleural fluid

180

2.78

10.27

1.2

1.6

mmol/l

0.03

105

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

511

3772

1.37

10.19

2.3

1.8

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

4.79

9.99

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1013

12383

0.80

9.96

4.8

4.3

32.1

32.5

0.43

685

8535

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

145

2.97

9.95

2.5

2.7

—

(3006576) Bicarbonate [Moles/volume] in Blood

353

2.22

9.89

9.0

6.5

25.4

24.8

mmol/l

0.87

320

(3004446) Plasmodium sp identified in Blood by Light microscopy

3.48

9.85

2.8

2.9

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

126

682

1.86

9.76

1.5

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.52

9.74

1.2

1.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

147

2.93

9.72

1.2

1.5

9.3

315007.1

nmol/l

1.08

120

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

3.44

9.70

5.9

2.9

1.3

1.0

mg/l

0.45

(3033799) Differential panel - Peritoneal fluid

299

2.31

9.70

2.7

1.8

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

281

2.36

9.66

1.9

1.7

118.8

144.1

au/ml

—

(3052592) Norovirus Ag [Presence] in Stool

210

2.58

9.58

1.2

1.3

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

292

1973

1.49

9.53

4.1

3.3

98.9

611.1

u/ml

2.75

257

1810

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

199

2.62

9.53

1.4

1.3

—

(3042517) Benzodiazepines panel - Urine

149

2.89

9.50

2.9

2.6

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

341

2.21

9.42

1.2

1.3

114.4

109.8

0.93

306

(3051651) Icteric interference index of Serum or Plasma

121

655

1.85

9.39

4.3

3.6

—

(3014891) Appearance of Pleural fluid

119

3.11

9.30

1.6

1.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

146

840

1.75

9.27

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

135

2.97

9.26

1.9

1.3

—

(3003129) Base excess in Capillary blood by calculation

257

2.38

9.16

1.9

1.7

1.4

0.6

mmol/l

0.75

239

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

231

1498

1.55

9.16

1.3

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

114

611

1.87

9.14

1.2

1.5

5.1

6.1

u/l

1.52

520

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

385

2.11

9.12

1.2

—

(40758292) HTLV I+II Ab panel - Serum

175

2.69

9.10

1.4

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

101

3.27

8.99

1.5

1.4

64.4

74.5

0.95

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

235

2.43

8.98

1.4

18.6

23.1

0.67

196

(3020650) Glucose [Presence] in Urine

298

2.25

8.90

1.6

1.4

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

6.67

8.88

1.1

1.4

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

102

535

1.91

8.76

1.1

1260.6

1555.8

miu/ml

2.59

102

535

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

3.41

8.74

1.2

83.3

120.8

ug/l

0.86

(3002621) Streptococcal DNAse B [Units/volume] in Serum

103

3.21

8.73

1.0

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

465

3471

1.35

8.68

1.7

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1404

11954

1.20

8.62

1.5

1.4

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

192

2.56

8.60

3.9

4.9

33.3

73.4

u/l

1.08

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

130

741

1.76

8.56

1.2

1.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

349

2.13

8.53

2.6

2.1

10.0

9.6

mg/l

0.17

290

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

276

3963

0.69

8.46

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1989

17469

1.16

8.38

1.6

1.5

—

(3019225) pH of Specimen

1203

10132

1.21

8.30

7.5

4.0

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

278

3972

0.69

8.30

1.4

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

232

2.38

8.28

1.7

1.5

14.3

13.4

g/l

0.27

181

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

279

3974

0.70

8.19

1.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

270

1855

1.46

8.17

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

277

3949

0.69

8.17

1.4

—

(3003740) Influenza virus B Ag [Presence] in Specimen

270

1856

1.46

8.15

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

4.53

8.10

1.1

1.0

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

7.86

7.98

1.2

1.0

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

117

661

1.78

7.98

1.2

1.1

ratio

0.06

235

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

233

1566

1.50

7.89

1.4

6.7

7.1

mmol/l

1.28

201

1126

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

225

2.36

7.88

1.1

—

(3016330) Potassium [Moles/time] in 24 hour Urine

137

2.78

7.87

1.3

—

96.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

921

7596

1.23

7.86

1.9

1.8

—

(3050129) First trimester maternal screen panel - Serum or Plasma

372

5005

0.74

7.74

1.4

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

167

2.58

7.72

1.1

5.8

4.1

pmol/l

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

530

1.86

7.72

1.2

1.1

46.0

13.0

u/ml

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

119

683

1.75

7.70

1.7

1.8

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

391

2.00

7.69

2.6

2.7

221.4

162.8

au/ml

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

331

2.09

7.66

2.4

2.0

643.7

4710.8

e6/l

0.84

229

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

105

583

1.81

7.61

1.1

0.9

9.5

nmol/l

2.31

123

(3027923) C peptide [Moles/volume] in Serum or Plasma

100

548

1.83

7.56

1.5

1.6

1.2

1.3

nmol/l

0.22

427

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

119

688

1.74

7.52

12.4

11.8

0.7

0.6

mmol/l

1.73

108

631

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

422

1.95

7.51

3.2

3.3

9.0

8.2

mg/l

0.30

330

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

249

2.25

7.51

1.1

1.2

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

102

564

1.81

7.50

1.5

9.5

7.6

ug/l

0.36

499

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

177

1134

1.57

7.49

3.1

3.2

5.3

11.2

nmol/l

0.62

172

1104

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

543

1.83

7.47

1.2

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

131

2.75

7.35

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

125

738

1.70

7.34

1.5

1.2

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

3.73

7.33

1.0

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

3.03

7.28

1.2

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

399

1.96

7.28

1.1

133.1

584.9

ng/l

1.52

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

3.29

7.22

1.3

1.1

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

542

1.81

7.22

2.4

2.3

209.4

200.2

u/l

0.65

537

(40765096) Chromosome analysis panel by Banding

286

2.14

7.20

1.2

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

125

744

1.69

7.13

1.5

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1131

9609

1.19

7.10

2.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

355

2.00

7.08

1.2

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

243

2.23

7.06

2.1

2.2

14.8

15.9

umol/l

0.36

243

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

391

1.95

7.00

2.2

2.4

156.7

153.8

nmol/l

0.09

333

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

469

1.86

6.97

1.2

1.3

—

(3044007) Cell count panel - Peritoneal fluid

264

2.16

6.96

2.2

1.9

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

124

2.75

6.93

1.4

1.6

—

(4034850)

245

3460

0.70

6.91

15.9

9.6

—

(3005033) Fetal Nuchal fold Thickness US

223

3198

0.69

6.86

1.4

1.5

—

(3002619) Bacteria identified in Specimen by Culture

227

2.25

6.86

1.5

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

103

588

1.76

6.84

1.1

1.0

689.9

738.0

ng/l

0.57

386

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

487

1.83

6.81

1.1

220.3

192.3

iu/ml

0.33

480

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

103

590

1.75

6.77

1.1

1.0

41.6

43.6

ng/l

0.21

392

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

262

2.14

6.68

10.3

7.4

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

377

1.94

6.67

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

232

3282

0.70

6.63

1.5

—

(3026726) Creatinine [Moles/volume] in Specimen

3.10

6.56

3.3

2.3

240.7

490.1

umol/l

0.61

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

227

2.21

6.44

1.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

402

3078

1.32

6.42

1.1

3.6

6.9

u/ml

1.32

393

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

101

586

1.73

6.38

1.1

1.0

309.7

323.6

ng/l

0.22

396

(3038071) Oxygen [Partial pressure] in Mixed venous blood

228

2.20

6.37

9.9

7.4

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

3.73

6.35

1.2

1.3

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

142

2.54

6.33

1.8

2.0

0.8

1.5

mmol/l

1.76

(3047352) Trisomy 18 risk [Likelihood] in Fetus

228

3205

0.71

6.30

1.4

1.5

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

566

1.74

6.29

1.8

1.7

1.9

2.8

u/field

0.79

395

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

371

1.92

6.29

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

4.21

6.27

7.0

8.9

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

296

2.03

6.26

2.1

1.9

23397.1

14374.9

e6/l

0.23

167

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

379

1.90

6.25

1.2

1.3

0.3

g/l

1.15

309

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

617

5014

1.24

6.11

3.6

3.2

43.8

55.8

u/ml

0.89

593

4834

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

226

2.17

6.09

1.3

—

(3016244) Insulin [Units/volume] in Serum or Plasma

116

708

1.64

6.09

2.8

3.3

25.2

28.3

mu/l

0.34

108

655

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

484

1.78

6.05

1.1

94.8

93.2

0.17

381

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

214

2.20

6.03

1.2

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

214

2.20

6.03

1.2

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

214

2.20

6.03

1.2

1.1

—

(3008898) HLA-B27 [Presence]

485

3846

1.27

5.94

1.1

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

142

916

1.56

5.93

1.7

2.2

18.5

19.2

nmol/l

0.30

136

866

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

101

2.78

5.87

1.2

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

3.52

5.87

1.1

—

(3017509) Phencyclidine [Presence] in Urine

137

2.49

5.75

3.1

1.5

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

4.65

5.73

5.3

3.7

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

252

2.07

5.72

1.2

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

3.23

5.71

1.3

2.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

501

1.74

5.69

1.9

1.6

3.0

9.4

nmol/l

0.71

410

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

699

5809

1.21

5.60

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

241

2.08

5.59

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

241

2.08

5.59

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

241

2.08

5.59

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

241

2.08

5.59

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

110

2.64

5.55

1.5

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

271

2.00

5.43

1.3

102.7

128.3

nmol/l

0.51

204

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

4.34

5.28

1.0

1.1

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

125

2.48

5.26

6.2

3.2

32.9

42.2

umol/l

1.56

105

(3049233) Organic acids panel - Urine

5.00

5.25

1.1

1.2

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

164

1123

1.47

5.22

1.6

7.2

7.7

mmol/l

1.73

104

671

(3024316) Viscosity of Plasma

3.64

5.19

1.0

1.5

1.6

mpas

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

163

2.27

5.18

1.1

—

(4281824)

152

1029

1.48

5.13

1.3

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

314

2403

1.31

5.12

1.4

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

115

2.52

5.10

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

285

1.93

5.07

1.3

1.2

38.3

39.9

g/l

0.31

151

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

2.84

5.07

1.2

1.3

1.2

1.1

ml/s/173m2

0.06

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

880

7544

1.18

5.03

1.6

1.5

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

272

1.95

5.03

1.2

1.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

128

2.42

5.02

1.1

1.2

0.0

0.4

u/ml

1.13

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

3.89

4.98

1.4

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

288

1.91

4.93

1.2

1.3

148.6

398.8

ug/l

0.80

155

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

121

788

1.54

4.93

1.0

1.1

300.0

286.3

mg/l

1.17

104

716

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

105

662

1.59

4.92

1.0

1.1

12.4

8.5

iu/ml

0.42

165

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

255

1906

1.34

4.91

1.5

0.3

0.4

nmol/l

4.01

193

1529

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

110

702

1.57

4.90

1.2

1.1

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

112

2.50

4.85

1.3

1.1

22.3

20.0

u/l

0.26

(3028717) Thiamine [Mass/volume] in Blood

118

2.46

4.85

1.1

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

235

2.00

4.82

1.1

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

3.79

4.80

1.1

1.2

3871.8

3440.7

ng/l

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

2.63

4.80

1.0

1.2

38.6

44.5

mg/l

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

263

1.94

4.79

1.2

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

131

2.37

4.79

1.1

1.0

—

(3024869) Neuronal Ab [Presence] in Serum

183

2.13

4.73

1.2

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

418

1.73

4.65

1.4

1.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

103

2.53

4.61

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

3.21

4.60

1.0

1.1

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

2.72

4.50

4.2

2.0

54.5

60.9

0.23

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

846

9766

0.86

4.49

1.7

1.6

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

270

1.89

4.46

1.2

1.1

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

111

727

1.53

4.45

1.2

5.9

12.3

u/ml

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

143

2.24

4.39

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

272

1.88

4.37

1.2

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

3.09

4.35

1.0

1.1

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

7.50

4.35

1.7

1.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

233

1754

1.33

4.33

1.2

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

391

1.72

4.28

1.2

1.5

13.3

15.3

pmol/l

2.16

319

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

185

2.06

4.23

2.3

2.4

—

(3013293) Extractable nuclear Ab [Presence] in Serum

152

2.17

4.22

1.9

1.7

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

281

2183

1.29

4.18

1.8

1.9

191.2

192.4

pmol/l

0.06

264

2065

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

113

754

1.50

4.18

1.2

59.3

69.7

u/ml

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

227

1.94

4.18

3.8

5.8

57.9

71.9

1.82

179

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

399

3234

1.24

4.17

1.6

1.7

39.6

41.7

nmol/l

1.00

391

3136

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

4.08

4.15

1.4

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

113

759

1.49

4.06

1.2

6.5

39.5

u/ml

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

413

1.67

4.04

1.0

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

601

1.55

4.00

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

118

803

1.47

3.98

3.2

2.5

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

211

1587

1.33

3.98

1.1

4.2

3.2

u/ml

0.24

760

(3050794) Legionella sp Ab [Presence] in Serum

2.60

3.79

1.1

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

2.84

3.78

1.0

1.2

54.6

25.3

u/ml

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

2.84

3.78

1.0

1.2

28.1

16.4

u/ml

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

229

1.88

3.75

1.3

1.2

308.0

279.4

pmol/l

0.32

160

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

160

2.06

3.74

1.3

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

332

1.72

3.72

1.5

1.2

—

(3038026) Centromere Ab [Units/volume] in Serum

113

774

1.46

3.72

1.2

68.9

50.8

u/ml

—

(3029396) Erythrocyte agglutination [Presence] in Blood

386

1.66

3.68

3.2

3.0

—

(3007463) Buprenorphine [Presence] in Urine

2.79

3.68

7.7

5.4

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.69

3.64

5.2

4.7

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.53

3.62

1.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

3.43

3.61

3.1

2.9

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

263

1.79

3.53

1.2

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

500

1.56

3.52

2.2

2.1

62.6

167.1

ug/min

0.97

123

(3032641) Amino acids panel - Urine

6.16

3.49

1.3

1.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1146

12735

0.89

3.48

11.0

7.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

152

2.04

3.44

1.3

1.1

—

(44813793)

107

738

1.45

3.43

1.0

1.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.98

3.40

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.66

3.38

1.1

1.3

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

254

2008

1.27

3.37

1.1

2.8

2.1

u/ml

0.21

533

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

188

1.92

3.36

2.3

1.5

164.5

125.8

ng/l

0.55

188

(3036071) Salmonella sp Ab [Titer] in Serum

358

1.65

3.35

1.1

—

(4094501)

317

2574

1.24

3.34

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

571

6630

0.85

3.33

1.5

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

352

4246

0.82

3.20

1.4

1.5

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

205

1596

1.29

3.11

1.1

6.4

5.4

u/ml

0.26

681

(44786800) Granulocytes/100 leukocytes in Body fluid

125

2.08

3.07

1.2

1.3

41.6

23.7

1.28

(40761535) Cells panel - Urine sediment

964

8637

1.13

3.05

5.1

3.4

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

5.00

3.04

1.5

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

3.45

3.04

1.6

2.0

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

2.50

3.03

4.2

2.0

11.9

16.3

—

(3032057) Clostridioides difficile [Presence] in Stool

218

1.79

2.99

2.0

1.8

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.75

2.98

1.1

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

10.00

2.98

1.2

1.0

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

134

2.02

2.94

1.3

1.1

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

657

1.43

2.87

3.4

3.1

116.1

134.7

nmol/l

0.30

650

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

5.39

2.86

1.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

527

1.48

2.84

1.5

1.8

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

194

1.81

2.78

1.5

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

110

2.09

2.77

5.7

9.5

—

(3026470) Cobalt [Mass/volume] in Blood

596

1.45

2.77

2.0

1.9

3.7

3.4

ug/l

0.15

514

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

131

1.99

2.74

1.3

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

499

1.49

2.74

1.2

1.1

25.2

26.1

u/l

0.05

385

(3020491) Glucose [Moles/volume] in Blood

114

833

1.37

2.72

2.2

1.9

7.2

6.4

mmol/l

2.20

619

(3025577) Chromium [Mass/volume] in Blood

583

1.44

2.69

2.1

2.0

1.9

2.3

ug/l

0.65

484

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

502

1.48

2.67

1.2

1.1

84.8

88.9

u/l

0.14

398

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.28

2.66

5.1

2.0

—

(40768793) Breast Pathology biopsy report

253

2062

1.23

2.66

1.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

164

1270

1.29

2.65

2.2

2.1

34.8

25.3

mg/l

0.94

321

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

343

1.58

2.63

1.2

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

375

1.55

2.62

1.8

2.5

1.3

1.2

ug/l

0.09

352

(3001019) Free T4 and TSH panel - Serum or Plasma

511

5857

0.87

2.58

1.5

1.6

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

259

2126

1.22

2.55

1.1

5.5

6.0

u/ml

0.17

144

1151

(3011335) Digoxin [Mass/volume] in Serum or Plasma

2.16

2.50

3.3

2.3

—

(3004616) Nuclear Ab [Presence] in Serum

157

1220

1.29

2.49

1.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1363

12579

1.09

2.48

1.7

1.8

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

494

1.46

2.48

6.7

5.9

39.5

7184.8

u/ml

0.57

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.11

2.48

1.1

1.0

—

(3030313) Adrenal Ab [Titer] in Serum

109

2.02

2.45

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

473

1.46

2.40

7.7

11.5

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

3.33

2.39

1.4

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

285

2380

1.20

2.38

1.2

1.1

1.8

u/ml

0.03

129

998

(3004347) Hepatitis D virus Ab [Presence] in Serum

3.64

2.36

1.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

113

848

1.34

2.33

2.1

2.0

2.5

1.9

u/field

0.49

335

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

2.09

2.32

1.1

1.0

19.4

12.2

iu/ml

—

(3010937) Rubella virus Ab [Presence] in Serum

2.12

2.28

1.1

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

4.62

2.27

1.0

—

(3001729) Color of Synovial fluid

2.15

2.24

2.3

1.4

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

2.27

2.24

1.1

2.6

5.0

u/l

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.27

2.24

1.1

—

(4024509)

129

994

1.30

2.22

1.7

1.5

—

(3002853) Influenza virus B Ab [Titer] in Serum

5.56

2.21

1.0

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

256

1.60

2.19

1.6

1.3

26.5

38.3

1.36

170

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.41

2.19

2.1

1.5

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.41

2.19

2.1

1.5

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.50

2.18

1.1

1.3

475.4

521.0

nmol/l

0.11

(3013166) Neutrophils/100 leukocytes in Synovial fluid

288

1.56

2.18

1.8

1.3

57.0

56.0

0.07

243

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

147

1156

1.27

2.18

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

136

1.84

2.16

1.0

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

219

1.65

2.14

1.2

1.3

43.9

100.0

mu/l

0.88

159

(3041672) Baker's yeast Ab [Presence] in Serum

2.36

2.11

1.0

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.56

2.09

2.3

1.7

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

5.00

2.07

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

2.05

0.0

1.1

—

(4212803)

2.00

1.99

1.0

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.08

1.96

1.3

1.1

9.6

13.4

u/l

0.38

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

3.75

1.93

1.0

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

3.18

1.88

1.0

1.2

1.1

1.5

u/field

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.15

1.87

1.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

2.65

1.86

1.0

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.86

1.86

1.1

1.3

—

mmol/l

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

3.53

1.83

1.3

1.2

104.3

101.4

nmol/24h

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

264

2251

1.18

1.83

1.6

1.4

125.2

132.1

pmol/l

0.10

257

2185

(3021691) Plasmodium malariae Ab [Titer] in Serum

4.17

1.82

2.6

2.5

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.12

1.81

1.1

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

130

1.77

1.80

1.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

207

1.60

1.78

1.8

1.5

0.4

ug/l

0.20

123

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.34

1.77

1.0

1.2

286.1

286.2

nmol/l

0.00

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.98

1.74

1.2

1.1

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

132

1.74

1.73

1.2

1.3

34.7

53.9

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

210

1.57

1.70

1.9

2.5

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

195

1.59

1.67

1.1

0.6

0.7

umol/24h

0.10

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

719

1.30

1.65

1.2

1.3

5.2

5.4

umol/l

0.16

668

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

196

1.58

1.64

1.2

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

120

1.75

1.61

3.6

2.3

0.5

u/field

0.09

120

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

128

1.72

1.59

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

237

2033

1.17

1.57

1.1

0.7

1.4

u/ml

2.15

104

903

(3018291) Platelet Ab [Presence] in Serum

3.33

1.52

1.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

166

1386

1.20

1.52

1.1

0.3

0.5

u/ml

0.56

339

(43055514) Macroprolactin [Presence] in Serum or Plasma

340

1.41

1.51

1.3

1.4

—

(3007919) Fasciola sp Ab [Titer] in Serum

2.86

1.50

1.3

1.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

686

1.28

1.50

2.5

2.4

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

202

1719

1.18

1.49

1.1

4.2

4.8

u/ml

0.15

700

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.95

1.48

1.6

1.1

—

(3016135) IgD [Mass/volume] in Serum

2.73

1.43

1.3

1.2

39.9

69.3

mg/l

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

2.03

1.43

1.2

1.5

14.3

20.0

pmol/l

0.44

(3027035) Albumin [Mass/time] in 24 hour Urine

1.79

1.42

1.4

1.3

—

477.1

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

1.85

1.39

1.1

1.0

6.2

8.2

u/ml

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.89

1.38

1.0

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

111

1.71

1.38

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

300

0.60

1.38

1.2

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

339

1.39

1.36

1.1

1.4

15.3

u/ml

0.84

200

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

165

1394

1.19

1.36

3.6

32.7

36.8

u/ml

0.19

159

1343

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

2.94

1.36

1.2

1.0

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

118

966

1.22

1.35

4.5

4.7

73.2

71.8

u/ml

0.02

299

(3036180) Methadone [Presence] in Urine

2.50

1.30

2.0

2.9

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

205

1771

1.16

1.30

1.5

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

2.78

1.28

1.0

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

114

1.67

1.27

1.2

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.86

1.23

1.0

—

(4038314)

1.91

1.22

1.2

1.3

—

(3011897) Casein IgE Ab [Units/volume] in Serum

212

1.46

1.22

1.4

1.3

1.9

3.1

u/ml

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

1.72

1.20

1.0

1.1

1.0

2.0

u/ml

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

682

1.25

1.20

1.0

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

101

1.68

1.19

3.8

3.0

6.3

6.8

—

(3025130) Human papilloma virus identified in Specimen

174

1497

1.16

1.19

1.6

1.7

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.88

1.17

1.3

1.2

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

117

1.62

1.17

1.0

1.1

0.0

1.0

u/ml

—

(40762814) Titanium [Mass/volume] in Blood

157

1.53

1.16

2.3

2.1

2.6

3.8

ug/l

1.69

(40761995) Spermatozoa Progressive [#/volume] in Semen

273

0.62

1.16

2.8

3.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.05

1.15

1.0

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

272

0.62

1.14

5.5

6.3

—

(44806071)

150

1.53

1.14

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

222

0.59

1.13

1.3

1.2

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.85

1.13

1.2

1.5

314.1

umol/24h

0.00

(3000285) Sodium [Moles/volume] in Blood

135

1.56

1.11

1.4

1.1

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.26

1.10

1.1

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

104

1.64

1.09

1.1

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.95

1.08

1.4

1.0

882.5

395.4

u/l

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.73

1.08

6.1

4.0

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

120

1.58

1.08

5.4

3.0

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

210

1.43

1.07

3.6

2.3

7.3

7.9

mmol/l

0.32

126

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.71

1.04

1.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.63

1.03

1.2

1.6

umol/24h

0.03

(44806420)

249

1.37

0.97

2.3

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.63

0.96

1.1

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

191

1.41

0.94

1.1

—

(3049242) von Willebrand panel - Platelet poor plasma

2.22

0.93

1.0

2.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

155

1767

0.88

0.91

1.6

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

455

1.25

0.90

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

194

1731

1.12

0.85

1.4

24.1

22.9

u/l

0.20

170

1435

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

120

1.50

0.85

1.0

1.1

0.3

3.7

u/ml

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

204

1.37

0.84

1.1

1.2

1.5

88.9

mg/l

1.42

153

(3034092) Cytoplasmic Ig cells/100 cells in Blood

145

1.45

0.84

10.1

8.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

213

1.36

0.84

1.5

1.2

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

1.75

0.83

3.8

3.1

—

0.0

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

129

1.47

0.83

1.9

2.8

60.4

63.4

pmol/l

0.06

113

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

111

0.54

0.83

1.0

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

512

0.78

0.82

1.2

1.1

9.2

10.0

u/ml

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

626

1.20

0.81

1.3

1.4

1.5

g/l

—

(3022670) pH of Venous cord blood

1.70

0.80

1.0

1.1

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

215

1.35

0.80

1.5

1.1

21.8

19.8

mmol/l

1.81

195

(4146454)

1044

0.85

0.79

2.7

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

224

1.34

0.79

1.3

1.1

0.2

9.3

u/ml

2.11

159

(3022475) Manganese [Moles/volume] in Blood

1.67

0.78

1.1

1.3

—

(3006270) Folate [Moles/volume] in Blood

105

907

1.16

0.77

1.2

323.0

365.3

nmol/l

1.34

779

(3035933) Granulocytes/100 leukocytes in Blood

340

1.27

0.76

1.0

1.8

—

(3009015) Lactate [Moles/volume] in Synovial fluid

1.52

0.75

1.1

1.2

6.6

5.7

mmol/l

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.08

0.74

1.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.00

0.72

1.0

1.4

1.5

2.9

mu/l

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.61

0.72

1.3

1.4

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

109

1.47

0.70

1.0

0.1

0.7

u/ml

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

109

1.47

0.70

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

610

1.18

0.69

6.7

6.6

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

213

1940

1.10

0.69

1.3

3.4

3.7

ug/l

0.36

193

1776

(3029612) Listeria sp Ab [Titer] in Serum

1.85

0.68

1.2

1.3

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.79

0.66

1.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.72

0.64

1.2

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

448

0.80

0.63

1.9

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.67

0.61

1.0

1.1

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1.46

0.61

1.1

1.2

14.5

14.8

nmol/l

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.60

0.0

6.3

—

0.2

—

(3013762) Body weight Measured

1.71

0.57

1.3

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

661

1.15

0.56

1.0

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.45

0.56

1.0

—

(3040893) Potassium [Moles/volume] in Capillary blood

1.62

0.55

7.0

2.1

4.1

4.4

mmol/l

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

204

1.27

0.53

1.2

1.6

0.3

0.2

nmol/l

0.42

146

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

170

1.29

0.51

10.8

7.6

—

(4133840)

312

0.80

0.48

1.3

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

154

1.30

0.48

1.6

1.5

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

197

1829

1.08

0.47

1.2

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.43

0.46

1.1

1.4

—

(3001556) Androgen free Index in Serum or Plasma

164

0.73

0.45

1.0

1.2

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

121

1.32

0.44

1.0

0.0

0.1

u/ml

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

1.36

0.41

2.8

1.7

0.6

0.7

umol/l

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.39

0.40

1.1

1.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

475

1.14

0.38

1.3

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

215

1.21

0.38

2.5

1.7

—

(3051101) Glucose [Moles/volume] in Cord blood

168

0.77

0.35

2.5

6.2

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

574

1.10

0.28

2.0

1.2

237.3

346.5

u/l

0.88

529

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.68

0.26

1.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.23

0.25

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

414

4014

1.03

0.25

1.9

1.6

6.5

3.5

mg/l

2.57

309

2768

(3015076) Soybean IgE Ab [Units/volume] in Serum

656

1.08

0.24

1.1

0.2

1.4

u/ml

0.91

103

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

361

0.89

0.24

1.1

5.9

7.5

u/ml

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

142

1.20

0.24

1.1

1.0

—

(40758358) Immune stain study

1.32

0.23

1.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.75

0.22

1.1

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

1.27

0.22

1.0

2.6

2.0

u/ml

—

(3012138) Guinea pig epithelium IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.4

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

108

1021

1.06

0.21

1.6

1.5

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.20

0.0

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

279

1.11

0.19

1.7

1.6

9.3

9.0

ug/l

0.16

279

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

1.15

0.19

1.0

1.1

—

(46235168) Fasting glucose [Moles/volume] in Blood

141

0.85

0.16

1.3

2.9

9.0

7.4

mmol/l

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.14

0.16

1.0

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

545

0.94

0.15

1.6

1.5

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

0.76

0.15

1.2

—

2.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

140

0.86

0.15

1.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

342

1.08

0.15

1.1

1.0

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

1.10

0.15

1.0

160.3

164.7

g/l

—

(3037556) Urate [Mass/volume] in Serum or Plasma

305

1.08

0.13

1.5

1.4

—

(3020874) Milk IgE Ab [Units/volume] in Serum

726

1.05

0.12

1.1

1.4

2.2

u/ml

0.36

237

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

182

1.10

0.11

1.1

—

(40768800) Prostate Pathology biopsy report

211

2065

1.02

0.10

1.2

—

(3009677) Dengue virus Ab [Presence] in Serum

1.14

0.10

1.0

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

106

1.13

0.09

1.2

1.5

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

635

1.04

0.09

1.2

1.3

—

(3019174) dRVVT (LA screen)

1.13

0.09

1.3

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

705

1.04

0.08

1.1

0.4

5.9

u/ml

0.98

196

(3005082) Progesterone [Moles/volume] in Serum or Plasma

764

0.97

0.08

1.3

1.4

28.1

31.7

nmol/l

0.70

695

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

226

1.06

0.06

3.3

2.5

195.2

123.1

ng/l

—

125

(3006462) Nitrate [Presence] in Urine

536

1.03

0.04

3.3

3.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

160

1586

1.01

0.02

1.7

1.6

—

(3015183) Erythrocyte sedimentation rate

569

0.98

0.02

1.2

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

137

0.95

0.01

1.2

1.1

2.6

u/ml

—

100

(40765089) Chromosome analysis panel - Blood by G-banded

418

0.98

0.01

1.1

1.0

—

(4211845)

585

0.99

0.00

3.4

3.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

826

1.00

0.00

1.5

1.3

50.6

101.2

pmol/l

0.75

256

(3006598) pH of Arterial cord blood

172

0.99

0.00

1.0

—

(3004959) Base excess in Arterial cord blood by calculation

172

0.99

0.00

1.0

-1.2

-2.9

mmol/l

—

(3044009) aPTT.lupus sensitive (LA screen)

1.04

0.00

1.3

1.2

—

(36031836) Tocilizumab [Mass/volume] in Serum

0.00

0.0

1.4

—

21.0

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

0.0

1.0

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

0.0

1.0

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

0.00

0.0

1.0

—

15.0

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

0.00

0.0

1.0

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(36304079) Mucus [Presence] in Urine sediment

0.00

0.0

1.0

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint U22_COVID19_CONFIRMED and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have U22_COVID19_CONFIRMED.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: U22_COVID19_CONFIRMED – Covid-19 confirmed case

GWS hits: 2

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Covid-19 confirmed case

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints